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Abstract
Although in clinical use for several decades, magnetic resonance imaging (MRI) is
undergoing a transition from a qualitative anatomical imaging tool to a quantitative technique for
evaluating myriad diseases. Furthermore, MRI has made great strides as a potential tool for
molecular imaging of cellular and tissue biomarkers. Of the candidate contrast agents for
molecular MRI, the excellent bio-compatibility and adaptability of perfluorocarbon nanoparticles
(PFC NP) has established these agents as a potent targeted imaging agent and as a functional
platform for non-invasive oxygen tension sensing. Direct readout and quantification of PFC NP
can be achieved with fluorine (19F) MRI because of the unique

19

F signal emanating from the

core PFC molecules. However, the signal is usually limited by the modest accumulated
concentrations as well as several special NMR considerations for PFC NP, which renders

19

F

MRI technically challenging in terms of detection sensitivity, scan time, and image
reconstruction.
In the present dissertation, some of the pertinent NMR properties of PFC NP are
investigated and new

19

F MRI techniques developed to enhance their performance and expand

the biomedical applications of

19

F MRI with PFC NP. With the use of both theoretical and

experimental methods, we evaluated J-coupling modulation, chemical shift and paramagnetic
relaxation enhancement of PFC molecules in PFC NP. Our unique contribution to the technical
improvement of 19F MRI of small animal involves: (1) development of general strategies for RF
1

H/19F coil design; (2) design of novel MR pulse sequences for

19

F T1 quantification; and (3)

optimization of imaging protocols for distinguishing and visualizing multiple PFC components
(“multi-chromatic” 19F MRI).

xvii

The first pre-clinical application of our novel 19F MRI techniques is blood vessel imaging
and rapid blood oxygen tension measurement in vivo. Blood vessel anatomy and blood oxygen
tension provide pivotal physiological information for routine diagnosis of cardiovascular disease.
Using our novel “Blood (flow)-Enhanced-Saturation-Recovery (BESR)” sequence, we
successfully visualized reduced flow caused by thrombosis in carotid arteries and jugular veins,
and we quantified the oxygen tension in the cardiac ventricles of the mouse. The BESR sequence
depicted the expected oxygenation difference between arterial and venous blood and accurately
registered the response of blood oxygen tension to high oxygen concentration in 100% oxygen
gas. This study demonstrated the potential application of PFC NP as a blood oxygen tension
sensor and blood pool MR contrast agent for angiography.
Another pre-clinical application investigated was functional kidney imaging with

19

F

MRI of circulating PFC NP. Conventional functional kidney imaging typically calls for the
injection of small molecule contrast agents that may be nephrotoxic, which raises concerns for
their clinical applications in patients with renal insufficiency. We demonstrated that our 19F MRI
technique offers a promising alternative functional renal imaging approach that generates
quantitative measurement of renal blood volume and intrarenal oxygenation. We successfully
mapped the expected heterogeneous distribution of renal blood volume and confirmed the
presence of an oxygenation gradient in healthy kidneys. We validated the diagnostic capability of
19

F MRI in a mouse model of acute ischemia/reperfusion kidney injury. We also employed

19

F

MRI as a tool to test the therapeutic efficacy of a new nanoparticle-based drug, i. e. PPACK (Dphenylalanyl-L-prolyl-L-arginine chloromethyl ketone) PFC NP, which was postulated to inhibit
microvascular coagulation during acute kidney injury. Based on our preliminary

19

F MRI

findings, we observed that PPACK PFC NP effectively reduced coagulation in our animal

xviii

model, as evidenced by lesser accumulation of particles trapped by the clotting process. This
finding suggests the potential for

19

F MRI to be used as a drug monitoring tool as well in

common medical emergencies such as acute kidney failure.
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1 Introduction
1.1 Quantitative molecular and functional imaging via MRI
Magnetic Resonance Imaging (MRI) has been widely adopted as a powerful diagnostic
imaging modality because of its superior soft tissue contrast and good safety profile compared to
other imaging approaches that employ ionizing radiation. In last two decades, researchers have
explored the transition of MRI from a tool for strictly anatomical depiction to a reporter of more
complex functional and molecular information. These new imaging techniques together with so
called “smart” contrast agents are designed to provide new disease biomarkers that identify early
disease stages and generate quantitative diagnostic matrices for disease detection, staging,
prognosis and therapeutic evaluation (1-3).
Molecular imaging in particular, entails the use of functionalized targeting ligands that
complex MR contrast agents to specific biochemical epitopes expressed on cell membranes. A
wide variety of targeting ligands already have been synthesized and deployed as components of
molecular contrast agent systems for noninvasive visualization of relevant biological signatures
in cancer and cardiovascular diseases (e.g., target for fibrin (4), angiogenesis (5), growth factor
(6) and endothelial adhesion molecule (7) et al).
In contrast to molecular MRI, functional MRI is focused on the systematic behavior and
physiological/pathological change of tissue and organ physiology in response to disease states or
external stimuli. To this end, the development of MRI techniques and “functional” MR contrast
agents might afford new opportunities for direct and noninvasive readout of essential
physiological indexes such as diffusion (8), perfusion (9), PH (10) and blood oxygenation (11),
among others.

1

Because molecular and functional imaging provide different but complementary windows
into the same pathological processes, interest is growing for devising potent platforms that
permit both molecular and functional readouts to delineate the underlying biological state of
cancer and cardiovascular disease in a more comprehensive manner (12-13). In terms of the
candidate contrast imaging nuclei for use with MRI, functional and molecular MRI might be
divided into two general categories: proton and non-proton imaging. Proton imaging would take
advantage of intrinsic or contrast-induced relaxation modulation of 1H spins, which can then
inform about the localized expression of biological markers or alternatively reflect specific
functional parameters revealed through the interaction of the contrast agent with important tissue
water compartments. Non-proton MRI would be useful for directly detecting clinically relevant
elements that exhibit net nuclear spins and could generate magnetization in an external magnetic
field, which then interact with tissues. As the default imaging paradigm, proton MR with
paramagnetic or superparamagnetic agents is technically translatable, but 1H based molecular
and functional applications often suffer from omnipresent 1H background signal, which may
hinder unambiguous identification of the expected molecular target or tissue functionality since
the background signal is admixed and heterogeneous. In contrast, non-proton contrast MRI might
be better suited to registering the specific presence of a disease biomarker or tissue function,
because there might be less interfering background signal. However, as an unavoidable tradeoff,
non-proton contrast MRI is typically more technically challenging because of the lower
gyromagnetic ratio and the inherently lower natural abundance of relevant exogenous contrastproducing atoms as compared to 1H spins (14).

2

1.1.1 Proton molecular and functional MRI
The distinctive power of 1H MRI originates from the wide selection of contrast mechanisms
that can be readily manipulated and engineered by modifying the chemistry of contrast agents,
pulse sequences and/or imaging protocols. These contrast mechanisms might be either
endogenous or induced by administrating extraneous contrast agents.
Currently, there are several relevant endogenous-contrast based functional imaging
approaches that are in or entering clinical use. Among them, diffusion weighted (tensor) MRI
takes advantage of water diffusion in soft tissue to produce an MRI readout that generates a
detailed mapping of tissue microstructures that establish restricting boundaries to water diffusion
(8). Arterial spin labeling (ASL) utilizes special pulse sequences to magnetically label arterial
blood flow (15). It is widely studied as an alternative method to traditional perfusion imaging
techniques, which otherwise might employ potentially nephrotoxic contrast agents. BloodOxygenation-Level-Dependent (BOLD) MRI permits non-invasive detection of neural activation
and metabolism by measuring T2* contrast generated by deoxygenated hemoglobin (11).
Exogenous contrast agents are usually engineered for specific applications and exhibit well
characterized biochemical properties. The contrast mechanisms of 1H functional and molecular
imaging usually entails one of several approaches

to modulate local

relaxation.

Superparamagnetic iron oxide (SPIO) particles generate local magnetic field inhomogeneities
that can be visualized using T2*-weighted gradient echo sequences (16). Paramagnetic contrast
agents such as Gd and Mn affect proton relaxation in proportion to their absolute concentration,
which can be represented by the signal intensity of T1-weighted images (17). Several other
contrast mechanisms (such as T1ρ (18) and CEST (19)) are intriguing but eventual clinical
adoption of these methods remains under investigation. However, for purposes of molecular

3

imaging, it is clear that all 1H based imaging techniques would require an extra scan to acquire a
pre-contrast baseline view since only relative changes in signal are examined upon contrast
localization, making these approaches highly susceptible to position shifts between the two
scans, which poses difficulties for fiducial image coregistration.
1.1.2 Non-proton molecular and functional MRI
In addition to protons, other nuclei exhibit net nuclear spins. Most of these nuclei (e.g.,
and

23

Na) have much lower gyromagnetic ratios (31P: 108.4µ106 rad∏s-1∏T-1,

23

31

P

Na: 70.8µ106

rad∏s-1∏T-1) and therefore dramatically different resonant frequencies from 1H (267.5µ106 rad∏s1

∏T-1). Despite their relatively low MR sensitivity,

31

P and

23

Na are widely exploited as

endogenous non-proton nuclei for functional imaging of tissue metabolism because they are key
elements of important organic and inorganic molecules that are naturally present in animals and
humans (20-21).
With respect to our interest in fluorinated agents for imaging that will be examined in depth
in this thesis, the gyromagnetic ratio of the 19F nuclear spin (251.8µ106 rad∏s-1∏T-1) is very close
to that of 1H. Because the MRI signal is proportional to the gyromagnetic ratio, at similar
concentration levels

19

F spins can generate comparable MR signals to those for 1H spins, both

being much stronger than that of other MR-active imaging nuclei. Moreover, because there is no
19

F background in human body (and animals) under physiological conditions, 19F imaging can be

performed without the need for a pre-scan. This unique feature of 19F MRI renders it a promising
imaging approach with extraordinary specificity. Finally, because

19

engineered into various organic molecules by substituting 1H,

F MRI with the use of

19

F atoms can be readily

appropriately functionalized contrast agents represents a versatile molecular imaging paradigm
for quantifying biomarker expression at the cellular and tissue level (22).
4

1.2 Perfluorocarbon nanoparticle as a MRI contrast agent
Perfluorocarbon (PFC) based nanoparticles (NPs) are a class of highly adaptable delivery
vehicles for targeted molecular imaging and a functional platform for noninvasive oxygen
tension (pO2) sensing. PFC comprises
hydrocarbons by substitution of 1H with

19

19

F-containing molecules that are derived from

F atoms. The PFC component has been clinically

approved as blood substitute for over 20 years and exhibits a good bio-safety profile because it is
biologically inert and not metabolized in vivo. The nominal size of a PFC NP is 200-250 nm in
diameter and the half life in the blood stream is 2-4 hours. The particles are cleared predominatly
by the liver and spleen and the PFC components are vaporized through the lung. In addition to
applications in diagnostic imaging, PFC NPs also have been developed as a potential vehicle for
drug delivery (23-26).
PFC NP formulation consists of a hydrophobic core of PFC molecules encapsulated within a
phospholipid surfactant monolayer coating. A variety of PFC compositions can be used to form
the PFC core based on a generalized synthetic procedure. Conventional 1H imaging contrast
agent (such as Gd chelates), fluorescence imaging moieties, drugs, and important targeting
ligands can be conjugated covalently or noncovalently to the surface of the lipid layer to
functionalize the PFC NPs. Therefore, PFC NPs serve as excellent candidates for molecular and
functional imaging of both 1H and

19

F MRI, although in this dissertation we will focus on

examining applications of PFC NP for 19F MRI.
1.2.1 Targeted molecular imaging using 19F MRI of PFC NP
Targeted PFC NPs actively bind to molecular biomarkers at disease sites and can be imaged
with the use of 19F MRI. It has been shown that 19F MRI can report sparse distributions of PFC
5

NP even at very low concentrations (i.e., picomolar nanoparticle levels) (27). As compared to
imaging PFC NP that incorporate Gd atoms as a contrast agent, when imaging the fluorine core
elements with

19

F MRI one can avoid potential renal damage or nephrogenic systemic fibrosis

that can be attributed to the systemic toxicity of the lanthanide components (28).
Applications of molecular

19

F MRI have been demonstrated in multiple preclinical animal

models simulating either cardiovascular disease or cancer in human. For example, tumor
angiogenesis could be successfully depicted by 19F MRI of αvβ3 integrin targeted PFC NP (29).
The same particle containing fibrin targeting ligands binds to unstable or disrupted
atherosclerotic plaques where rupture exposes the arterial wall to clot formation. In this
particular application,

19

F MRI offers a quantitative readout of local particle concentration and

confirms the expected heterogeneous accumulation of PFC NPs throughout the vascular wall
(30). Moreover, in cases of very advanced plaques with endothelial barrier disruption, PFC NP
without any targeting ligands passively penetrate into these plaques to reveal highly permeable
and disrupted lesions that might portend eventual heart attack or stroke (31). Furthermore,
advanced MR pulse sequences (e.g., diffusion weighted

19

F sequence (32)) in association with

other targeting moieties (e.g., adhesion molecules such as vascular cell adhesion molecule, or
VCAM (7)) may extend

19

F molecular imaging to early detection of inflammatory vascular

disease.
1.2.2 Cell tracking using 19F MRI of PFC NP
Another important application of PFC NP for19F imaging is cell tracking. Multiple cells types
can be labeled with PFC NP for in vivo tracking after injection as tissue regenerative therapies in
preclinical models, e.g., heart ischemia (33), lung injury (34) and organ transplant (35), among
others. Among all cell types, the macrophage is the most widely studied because of its critical
6

role in vascular inflammatory processes. Macrophages can be labeled with PFC NP either
through in vitro incubation or in vivo labeling in blood stream. Macrophages internalize PFC
NPs through endocytosis and then actively home to the disease regions without any observable
loss of cellular functionality.

19

F MRI enables a noninvasive measurement of the macrophages

recruitment, which is an essential component of plaque inflammation (36). In addition to
macrophages, various stem cells (37) and immune dendritic cells (38) have been labeled with
PFC NP. Accordingly, in vivo tracking of stem cells labeled with unique, no background fluorine
signatures could provide a useful imaging approach for monitoring on-going trials of stem-cell
therapy.
1.2.3 PFC NP as an oxygen sensor
Because of the long residence time (2-3 hours) in blood stream, PFC NP can be employed as
a blood pool contrast agent in near steady state conditions. Conventional study of neat PFC
molecule has revealed that the relaxation time of

19

F (or, R1 = 1/T1) is linearly correlated with

local oxygen tension. In these studies, PFC was administrated directly into solid tumors followed
by 19F T1 measurement to generate oxygenation mapping. It has been demonstrated in previous
reports that

19

F MRI of PFC NP was more sensitive to detect tumor hypoxia as compared with

conventional BOLD MRI (39).
Functional
19

19

F imaging with PFC NP also has been validated in other organs. For example,

F MRI of PFC NP has been utilized as a non-invasive method to evaluate oxygen tension in

livers and spleens, because most PFC NPs are trapped by reticuloendothelial system after being
cleared from the blood stream (40). As another interesting application of functional imaging with
PFC NP, Duong et al proposed a new method for measuring arterial and venous blood fraction in
mouse brain (41) by combining absolute quantification of 19F concentration and 19F T1.
7

1.2.4 PFC NP as a 1H molecular imaging contrast agent
Applications of PFC NP containing large quantities of Gd (100-200,000 atoms as chelates)
for use as a 1H contrast agent for molecular imaging have been extensively investigated in
preclinical models of cancer and cardiovascular disease, among which angiogenesis imaging
appears most promising (42). In this case, targeting the PFC NP to the αvβ3 integrin, which is
present in large quantities on newly forming blood vessels in cancers and atherosclerosis,
facilitates active binding to locations where new blood vessels are sprouting. Because the Gd
payload is situated on the surface of PFC NP, a direct inner-sphere dipole-dipole interaction
occurs between Gd and the water molecules in the vicinity of the αvβ3-integrin targeted sites. The
magnitude of the relaxation effect is dependent on the chemical structure of the Gd chelates, and
those chelates with very short lipid linker segments (Bis-oleate-DTPA) that partially hide the Gd
at the particle surface manifest lesser effects than do those with longer lipid linker chain (e.g.,
DOTA-DPPE) that allow more flexible exposure to surrounding waters. (43). Conventional T1weighted spin echo or gradient echo sequences can be employed to visualize accumulation of
particles in vivo. Other combinations of targeting ligands (e.g., α5β1 (44) and Robo4 (45)) and
imaging agents on PFC NP (e.g Mn (46)) have been formulated and validated in preclinical
disease models.

1.3 Technical challenges of 19F MRI
Although

19

F MRI of PFC NP has undergone rapid growth in last 10 years and presents a

promising future for eventual deployment in clinical settings, this new imaging paradigm is still
in its early technical development stages and will benefit from further technical advances to
bridge the gap between laboratory investigations and clinical utility. Compared to 1H MRI,
8

19

F

manifests no appreciable background signal, and so the signal strength for 19F MRI is limited by
the modest doses of fluorine that can be administered as PFC NP. Therefore, it is critical to
improve imaging methodologies to enhance the detection limits for PFC NP that typically are
present in low concentrations. Moreover, accurate quantification of PFC NP in vivo requires
robust imaging methods immune to potential field inhomogeneities associated with the imaging
system (B0, B1 and sensitivity), because the spatial distribution of PFC NP for molecular
imaging is generally heterogeneous, as a consequence of the individual expression patterns of the
targeted pathological epitopes, which are typically sparse in tissue. Finally, in contrast to 1H
atoms in water,

19

F atoms in PFC experience a more complicated chemical environment, which

might result in multiple chemical shifts and scalar coupling (J-coupling) between different
groups, all of which complicates the imaging objective.
1.3.1 Signal to Noise Ratio (SNR)
There are two major factors limiting the potential MR signal strength for 19F MRI: one is the
total number of

19

F nuclei present in the targeted tissue and the other is the Boltzmann

distribution which leaves only a small portion of all the

19

F nuclei generating observable

magnetization. Several approaches have been pursued to improve SNR in
accepted that improving the sensitivity of

19

19

F MRI. It is well

F RF coils is the most straightforward approach to

increase image quality. It is necessary to design application-specific RF coils which are suitable
to particular imaging animals and organs and thus avoid RF loss on redundant components (low
filling factor) of the RF coils. Moreover, improving electronic design of RF coils and enhancing
the quality factor (Q value) of RF circuits might also substantially improve the receive
sensitivity. Besides RF coils, pulse sequences also are targets for optimizing 19F imaging. It has
been shown that different pulse sequences might yield over 3-fold better SNR for the same
9

imaging subject (47). Therefore, it is essential to design or choose appropriate pulse sequences
that are suitable for specific

19

F imaging applications. Recently, researchers have reported

several pioneering trials to develop hyperpolarization technique for 19F spins (48). Theoretically,
by hyperpolarizing

19

F spins,

19

F spins could break the thermal equilibrium state (Boltzmann

distribution) and produce several orders of magnitude stronger MR signals.
1.3.2 Quantitative methodology
19

F MRI is quantitative in principle because 19F spin density is linearly correlated to the PFC

NP concentration and

19

F relaxation directly reflects oxygenation. However, in most in vivo

applications, many other factors might come into play and affect the measurement accuracy of
19

F MRI. For example, 19F quantification might suffer from field inhomogeneity of the transmit

and receive coils. Moreover, the measured 19F signal might not only reflect 19F concentration but
be convoluted with other factors that might induce changes of 19F T1 and T2 et al. Similar to 1H
MRI, 19F also is susceptible to imaging artifacts, such as motion and eddy current artifacts, all of
which compromise image quality and generate unexpected errors for quantification (29).
Therefore, in order to achieve reliable and reproducible 19F MRI measurements across different
applications, it is necessary to implement robust correction methods and optimized artifactresistant pulse sequences.
1.3.3 J-coupling and chemical shift
PFC molecules are more complicated than water in terms of their NMR properties. PFC can
exhibit multiple chemical shifts, and

19

F atoms from different chemical groups can also have

strong interactions with each other. Therefore, imaging

19

F spins in PFC molecule can be more

challenging than is 1H imaging. For example, chemical shifts might cause shift artifacts along the
readout gradient direction, and special reconstruction algorithms are needed to correct for these.
10

Moreover, J-coupling between different chemical groups in PFC molecule causes “T2-shortening
like” behavior in spin echo-based MRI, i.e., J-modulation, which significantly reduces the
detectable signal intensity for

19

F imaging. However, once the underlying physics of these

special NMR features of PFC NP are accounted for, we can avoid the resultant artifacts or even
take advantage of these properties and expand 19F MRI to additional applications (49).

1.4 Dissertation objective and organization
1.4.1 Overarching objective
The objectives of this dissertation are three fold. (1) We aimed to understand the physical and
chemical properties of PFC NP that are related to its applications as a

19

F MRI contrast agent.

We will build up physical models that apply quantum mechanical principles to investigate the
spin dynamics of 19F nuclear spins in an external magnetic field, and to examine the interaction
between 19F spins and other nuclear spins and electron spins. (2) Based on the theoretical frame
work of

19

F spin dynamics and MRI engineering, we seek to implement novel MRI imaging

techniques including pulse sequences, RF coils, imaging protocols and chemical modifications to
enhance and expand the use of PFC NP-based functional and molecular
animal models. (3) With the newly developed
new biomedical applications of
include a novel

19

19

19

19

F MRI in preclinical

F MRI techniques, we will devise and validate

F functional MRI in small animal models. These applications

F MRI based rapid blood oxygenation measurement method and a new

comprehensive diagnostic approach for evaluating kidney endothelial damage based on 19F MRI
of circulating PFC NP. We anticipate that these preclinical studies should demonstrate the
superior diagnostic capability of

19

F MRI and can be readily translated to real world clinical

applications.
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1.4.2 Organization
Following the introduction, in Chapter 2, we present a general coupled resonator model and
validate this model as a universal strategy for building 1H/19F dual frequency RF coils. We also
summarize and investigate the general requirements for designing transmit and receive coils for
19

F MRI and validate our methods in phantom and in vivo studies. This chapter has been

published in Journal of Magnetic Resonance Imaging, Volume 34, Issue 1, pages 245–252, July
2011
In Chapter 3, we establish physical models and propose theoretical treatments for the NMR
properties of PFC NP. We investigate the effect of oxygenation on the absolute quantification of
PFC concentration in vivo and in phantoms. In this part, we propose general criteria for
achieving consistent and highly sensitive PFC quantification that is robust against oxygenation
effects on relaxivity. Using a density matrix calculation and Hamiltonian time-evolution, we
investigate theoretically the J-coupling induced amplitude modulation effect in PFC NP and
develop a method to suppress the potential imaging artifacts associated with this effect. In the
end, we study the chemical shift effect of PFC NP, from which we propose a “multi-chromatic”
19

F MRI technique for selectively imaging of multiple PFC NPs separately in the same imaging

subject.
In Chapter 4, we examine the interaction between

19

F spins inside PFC NP with

paramagnetic ions on the surface or in the surrounding solution. In this part, the paramagnetic
relaxation enhancement effect of Gd on

19

F is calculated theoretically with the use of quantum

perturbation theory. We observe that short-linker paramagnetic chelates that are covalently
conjugated to the surface of PFC NP may significantly enhance 19F relaxation and this effect is
modulated by cellular endocytosis and particle lipid breakdown mechanisms in endosomes as a

12

probe of cellular activation. This chapter has been published in Journal of Magnetic Resonance
Imaging, Volume 34, Issue 3, pages 653–661, September 2011
In Chapter 5, we exploit PFC NP as a blood pool contrast agent for angiography and blood
oxygenation sensing. We demonstrate the application of PFC NP as a blood oxygen tension
probe with the use of a novel blood-flow enhanced saturation recovery (BESR) pulse sequence.
Compared to the traditional Look-Locker sequence, the BESR sequence is insensitive to B1 and
B0 field inhomogeneity and pulsatile blood in-flow effects. Compared to traditional invasive
measurements using cardiac catheterization, the BESR sequence provides a simple and rapid
method for non-invasive assessment of blood oxygenation in vivo.

This chapter has been

published in Magnetic Resonance in Medicine, DOI: 10.1002/mrm.24436.
In Chapter 6, we develop a new 19F functional MRI technique for kidney imaging. We first
validate the feasibility and durability of our technique for measuring renal blood volume and
intrarenal oxygenation in healthy kidneys. The measured regional intrarenal blood volume and
oxygenation appears to be consistent with prior experimental observations. In a mouse model of
ischemia-reperfusion acute injury,

19

F MRI of PFC NP is shown to delineate reduced blood

volume at cortico-medullary junction and vascular leakage at medulla as a consequence of
endothelial damage. Finally using

19

F MRI as a treatment evaluation tool, we confirm the

treatment effect of a novel PFC NP based anti-clotting drug for inhibiting intrarenal coagulation
during acute kidney injury. This chapter is under revision for Magnetic Resonance in Medicine.
In the last Chapter, we summarize these findings throughout the dissertation, and discuss
future work for PFC NP based functional and molecular 19F MRI.
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2 General strategy for building 1H/19F RF coils
2.1 Background
Dual-nuclei

19

F/1H MRI/MRS is emerging as a novel imaging technique for molecular

imaging and quantification of tissue pathology that features both rapid acquisition with high
spatial and temporal resolution (1H) and unique, no background spectral signatures (19F) (1).
However, MRI of fluorinated contrast agent suffers principally from low sensitivity especially at
clinical field strengths, even despite the fact that

19

F is a high signal nucleus, requiring

millimolar quantities of contrast agent per voxel for detection (2). Because the amount of
fluorine achievable by molecular targeting is limited by the concentration of epitopes that bind
the contrast agent, which itself is a function of the tissue pathobiology, improvements in
sensitivity and speed are better addressed with the use of specialized and dedicated RF coils.
Such coils could be designed to simultaneously achieve high signal-to-noise ratio (SNR) and
homogeneous acquisition for detecting and quantifying molecular biomarkers with dual-nuclei
19

F/1H MRI.
Previous studies typically used single-frequency mode RF coils for 19 F/1H MRI. A common

approach is to use frequency tunable coils, in which case the coil must be tuned to either 19F or
1

H frequency to maximize SNR at the cost of extra time for coil tuning and positional shifting of

the imaged object (3). Alternatively, a two-coil setup with a volume coil for 1H imaging and
surface coil for

19

F imaging introduces inherent sensitivity profile differences at the two

frequencies (4). Finally, the usage of auto-tuned RF coils that can switch resonant frequency
with the assistance of an external computer program entails extra complexity and the associated
higher cost of the imaging system (5). Thus, the use of single-frequency mode RF coils for

21

19

F/1H MRI imaging poses a number of limitations including challenges in simultaneously

achieving high sensitivity and B1 field homogeneity, and inaccurate co-registration of 1H/19F
signals due to positional artifacts caused by coil retuning (6). It has been shown that these
limitations may be minimized with the use of dual-frequency mode RF coils for multi-nuclear
MRI/MRS (7).
Regarding the details of coil design, the commonly used shunting method and multiple poles
method for designing dual-frequency coils work well when the two resonant frequencies are well
separated, e.g., for 1H (42.58 MHz/T) and
well suited for designing

19

13

C (10.71 MHz/T). However, such methods are not

F/1H MRI coils (8-9) because the gyromagnetic ratio of

19

F (40.08

MHz/T) is close to that of 1H (10). Several dual-frequency strategies have been proposed for
MRI/MRS at close frequencies but each has limitations. A universal matching circuit for multinuclei NMR has been proposed (11), but it requires multi-port inputs for multi-frequency.
Alternatively, several dual-frequency strategies for close and well-separated frequencies have
been proposed based on the special resonant property of a birdcage resonator (12-14). In these
works, the two crossed cages or two different modes of a birdcage are utilized to achieve the
double resonance, so these techniques are only suitable for coils with birdcage geometry, and
could lead to different B1 field distributions at the two frequencies. Recently, a novel

19

F/1H

dual-frequency solenoid coil with identical field distribution at two frequencies at 3 T has been
proposed by researchers at Philips Research based on the coupled resonator model (15).
However, it remains unknown whether this concept establishes a general RF design approach for
such RF coils considering the various geometrical and electrical parameters required to fit the
needs of diverse experimental situations (16).
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In the present work we seek to develop the coupled resonator model as a universal technique
to design and fabricate 19F/1H dual-frequency coils in diverse configurations. Due to the different
impedances at the two resonant frequencies, matching for a dual-frequency coil remains a critical
challenge in practical application. Accordingly, the electrical properties of the coupled resonator
model were considered and a numerical calculation was executed to prove that a series capacitive
matching network is theoretically effective in matching the coupled resonator to 50 Ohm at both
19

F and 1H frequencies (9,17). A 19F/1H dual-frequency birdcage RF coil for in vivo imaging at

4.7 T was implemented to illustrate the feasibility of the model. Finally, for an experiment
requiring high imaging SNR within a short acquisition time, an actively-decoupled 19F/1H dualfrequency saddle coil was built. We show that using the saddle coil for 19F and 1H excitation and
using an actively-decoupled surface coil on

19

F frequency for both

19

F and 1H signal receiving,

the two-coil setup can achieve homogeneous excitation with high sensitivity for

19

F MRI while

retaining sufficient SNR from 1H signal for anatomy images.

2.2 Material and Methods
2.2.1 Coupled resonator model
In the present coupled resonator model, the RF sample coil is connected to a secondary
inductor and capacitor (LC) resonator with a coupling capacitor in series (Figure 2.1a). For
nuclei with close resonance frequencies, such as 1H and 19F, the inductance of a MR sample coil
can be treated as a constant value. Following the theoretical analysis proposed by Haase et al
(18), when the secondary resonator is built with identical frequency to the sample coil, two
possible oscillating modes are formed within the circuit, namely in-phase and anti-phase modes.
When resonating at the in-phase mode, the two resonators of the circuit have equal electrical
23

potentials, and thus the voltage and current across the coupling capacitor always remains zero. In
this case, the coupling capacitor can be virtually removed and then the equivalent circuit of the
coupled resonator can be drawn as Figure 2.1b with the resonant frequency

ωhi = γ H B = 1/ LCt1 .

[1]

In contrast, for the anti-phase mode, the electric potential at both sides of the coupling capacitor
is opposite, so the voltage at the middle point of coupling capacitor remains zero. For circuit
analysis, a virtual short wire can be added between the ground and the middle point of the
coupling capacitor (Figure 2.1c), and thus it gives rise to a different resonant frequency

ωlo = γ F B = 1/ L(Ct1 + 2Cc ) .

[2]

Given the gyromagnetic ratios of 1H and 19F, when

Cc / Ct1 = 0.064 ,

[3]

the two frequencies of the coupled resonator correspond to 1H and 19F frequencies, in agreement
with the analytic calculation of transfer impedance (19).
2.2.2 Impedance matching
Impedance matching is critical in dual-frequency coil design, because the circuit impedance
could be different at the two resonant frequencies. For the coupled identical resonator model
(Figure 2.1d), specifically, by inverting the admittance of the parallel components, the
impedance of the coupled resonator is

Z hi =

X L + r1
1 + ( X L + r ) X Ct1

[4]

at high frequency or in-phase mode; and

Z lo =

X L + r1
1 + ( X L + r )(2 X Cc + X Ct 1 )

[5]
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at low frequency or anti-phase mode.
In the proposed dual-frequency coil design (Figure 2.1d), the coupled resonator is
connected to the MR scanner at the end of the secondary resonator in series with a capacitor
matching circuit. In this case, a small detuning of two resonators, which renders them slightly
off-resonance, is able to introduce an extra degree of freedom and compensate for the impedance
difference (18). To show the coupled resonator can always be matched to 50 Ohm with the use of
appropriate values for tuning, coupling and matching capacitors, we numerically calculated
several realistic circuit examples corresponding to various combinations of internal resistances of
the sample coil and secondary resonator. With no loss of generality, we assumed that the sample
coil with an inductance 32 nH, which is equal to the inductance of the secondary resonator, is
designed to work at 4.7 T for dual-frequency 19F and 1H imaging. A custom-developed program
in Mathematica (Wolfram, USA) was used to seek for the appropriate values of Ct 1 , Ct 2 , Cc ,
and C m to match the circuit at both frequencies (188 MHz and 200 MHz). In the program, the
preset values of Ct 1 , Ct 2 , Cc were first calculated according to Eqs. 1-3; then C m was set to be
a qualitatively correct value according to Eqs. 4-5; finally, a nonlinear root-seeking algorithm
was carried out to vary all the capacitances around their preset values to successively achieve
impedance matching.
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Figure 2.1 Schematic diagram of a coupled resonator circuit. (a) the resonator formed by
capacitor Ct 2 and probe (with inductance L ) is capacitively coupled, by capacitor Cc , to the
secondary resonator formed by capacitor Ct 1 and inductor L . (b & c) the equivalent circuit of
in-phase and anti-phase mode. (d) coupled resonator is capacitively matched to 50 Ohm with C m
.
2.2.3 Implementation of two typical designs of volume coils for 1H/19F MRI at 4.7 T
To prove the general application of the concept, two typical designs of 19F/1H volume coils
were implemented. The first design was a transmit/receive birdcage coil for the whole body
imaging and the second design was an actively-decoupled saddle coil that can be used with other
actively-decoupled 19F surface coils for high resolution cardiovascular imaging. Both coils were
designed to work on a Varian 4.7 T small animal scanner, with 19F and 1H resonant frequencies
of 188 MHz and 200 MHz, respectively.
The high-pass 8-leg birdcage coil (Figure 2.2a) was built with adhesive copper tape on an
acrylic tube of 50 mm diameter and 128 mm length. The whole coil was placed in a copper
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shield with a diameter 135 mm and then the 1st resonant mode of the birdcage coil was tuned to
200 MHz (20). The secondary resonator was built with a tunable capacitor in parallel with a
custom-made inductor, which has a diameter of 4 mm and the same inductance with the sample
coil. The secondary resonator was positioned >5 cm away from the sample coil to minimize
inductive coupling between two circuits. The coupling between the sample coil and secondary
resonators was implemented with another tunable capacitor in series with a fixed value capacitor
on the other port for the purpose of balancing. The secondary loop also was tuned to resonance at
200 MHz. The value of coupling capacitor was then adjusted to over-couple these two resonators
giving rise to the second distinct frequency at 188 MHz (20). The feed point for this coil was
located at the secondary resonator input and the whole circuit was matched to 50 Ohm with a
tunable capacitor and fixed value capacitor.
The actively-decoupled saddle coil (Figure 2.2b) was made with adhesive copper tape on an
acrylic tube of 70 mm diameter and 40 mm length. Four fixed value capacitors were evenly
distributed along the coil to maintain the constant current distribution within the coil. The end of
the coil was connected to fixed value capacitors in parallel with a variable capacitor. The
secondary resonator was built with a custom made inductor in parallel with a fixed value
capacitor and variable capacitor. The coupling and matching circuit configuration was the same
as the dual-frequency birdcage and uses variable capacitors in series with fixed value capacitors.
The actively decoupling method for the saddle coil was the same as mentioned in previous study
(9). In order to enable the decoupling switching circuit to be compatible with the dual-frequency
circuit, an RF choke (RFC) and PIN diode were inserted in the leg of the sample coil and
controlled by a separate coaxial cable.
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Figure 2.2 RF coil circuits and evaluation.

(a) dual-frequency transmit/receive high-pass

birdcage coil for 4.7 T. (b) dual-frequency actively-decoupled saddle coil for 4.7 T. (c) S11 of
dual-frequency birdcage coil. (d) S11 of actively-decoupled dual-frequency saddle coil when
switched on and off.
2.2.4 Bench test of electromagnetic performance
Laboratory bench tests were performed on a network analyzer (Hewlett Packard 8751A). For
the tuning and matching procedure, there are a total of four variable capacitors to be adjusted for
each coil. Tuning capacitors for the sample coil and secondary resonator were first adjusted to
tune the two resonators to essentially the 1H frequency. Then the coupling and matching
capacitors were adjusted to achieve the second frequency at 188 MHz, followed by matching the
dual-frequency coil impedance to 50 Ohm. The coil return loss (S11) of two coils was by using a
50 ml tube filled with saline to mimic the electrical load of a live mouse. The quality factors (Q)
were measured from S11 as described in (9). S21 measurement of the B1 fields produced by the
28

sample coils was performed with a 10 mm shielded loop for signal pick up. For the activelydecoupled saddle coil, transmission properties were measured when the coil was switched to
“on” and “off” state, respectively.
2.2.5 Phantom and in vivo imaging
A 1H image of a 50 ml tube was acquired with the dual-frequency birdcage coil or activelydecoupled coil pair (with dual-frequency transmit saddle coil and single-frequency

19

F surface

coil), respectively. Image acquisition parameters were: pulse sequence, gradient echo; TR, 20
ms; TE, 4 ms; number of average, 1; in plane resolution: 0.4 mm * 0.4 mm; slice thickness, 0.2
mm. Normalized intensity profile was calculated along the axial direction of acquired images.
To evaluate the induced signal loss in the secondary resonator, we compared the SNR of the
same phantom by setting the coil under single and double-frequency modes. Specifically, the
actively-decoupled circuit of the saddle coil was manually shorted to operate the coil in
transmit/receive mode. The single-frequency mode was achieved by removing the secondary
resonator circuit. A 50 ml tube filled with saline and 10% perfluoro-15-crown-5-ether (CE)
emulsion was imaged with a gradient echo sequence. The formulated CE emulsion is composed
of 20% (or 40%) (v/v) of CE (Exfluor Research Corp., USA), 2.0% (w/v) of a surfactant
commixture, and 1.7% (w/v) glycerin, with water comprising the balance (21).
The imaging quality with the transmit/receive dual-frequency birdcage coil was evaluated for
whole body mouse 19F imaging on the Varian 4.7 T small animal scanner. A C57Bl/6 mouse was
anesthetized with a standard dose of ketamine/xylazine followed by intravenous injection of
4ml/kg CE emulsion (20% v/v). Multi-slice axial 1H and
acquired.

19

19

F images of the mouse body were

F MRI parameters were: pulse sequence, gradient echo; TR, 40 ms; TE, 4 ms;

number of average, 1024; in plane resolution, 1.8 mm * 1.8 mm; slice thickness, 10 mm.
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The efficiency of the actively-decoupled dual-frequency saddle transmit coil was
demonstrated by
used

19

F angiography in a mouse (22). An actively-decoupled

for receiving.

Specifically,

a Swiss

Webster mouse was

19

F surface coil was

anesthetized

with

ketamine/xylazine as above followed by intravenous injection of 40% v/v perfluoro-15-crown-5ether (CE) NP (5ml/kg). 2D time-of-flight and whole projection gradient echo sequences were
used to acquire the 1H and

19

F image of blood vessel in the neck, respectively (23).

1

H/19F

imaging parameters were: TR, 80 ms; TE, 4 ms; number of average, 4 for 1H imaging and 512
for

19

F imaging; voxel resolution, 0.27 mm*0.27 mm*0.4 mm for 1H imaging and 0.8 mm*0.4

mm*10 mm for 19F imaging; 90 degree pulse width at 45 dB RF output power, 280 µs for 1H and
310 µs for 19F.

2.3 Results
Photographs of dual-frequency 1H/19F volume coil, the associated surface receive coil and the
4.7 T small animal MRI scanner that that was employed in this study are shown in Figure 2.3.
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Figure 2.3 Photographs of RF coils and 4.7 T small animal scanner. (a) Double-tuned high pass
birdcage coil of 50 mm in diameter placed in a copper shield with a diameter of 135mm. (b)
Active decoupling surface coil as a possible choice as receiving probe. (c) Geometric and active
decoupling were utilized to reduce the interference between two coils. (d) Probes were tested on
Varian 4.7-Tesla ANOVA console.
2.3.1 Numerical calculation of impedance matching
Numerical solutions for the tunable capacitors to optimize impedance matching were
obtained using the root-seeking program. For various combinations of internal resistances of the
sample coil and secondary resonator, the calculated relative capacitances are listed in Table 1.
Although the numerical results exhibited small variations (<3 pF) from the analytic solutions of
the ideal coupled resonator model, they were found to closely approximate the preset analytic
values, indicating that the fundamental physical features of the coupled resonator are represented
in a realistic coil design.
Table 1 Nonlinear Root-Seeking of Capacitance Values for Impedance Matching
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2.3.2 Tuning, matching, and sensitivity profile
Figure 2.2c&d depict the S11 of two dual-frequency coils at their working frequencies. All
coils achieved impedance matching at both 1H and

19

F frequencies. When the PIN diode was

switched on, the saddle coil was detuned from both 1H and

19

F frequencies. The unloaded Q

values for birdcage and saddle coils were 200 and 144 at 1H frequency; 106 and 95 at

19

F

frequency. The loaded Q values for birdcage and saddle coils were 58 and 66 at 1H frequency; 80
and 84 at

19

F frequency. Figure 2.4 shows the B1 field distribution, measured from

corresponding coupling intensity in S21, of the birdcage coil and saddle coil working at both 19F
and 1H frequencies. For the birdcage coil, the fluctuation of magnetic field strength was less than
10% for > 60% area in radial direction and > 75% of area in axial direction (Figure 2.4a&b).
When the saddle coil was switched on, the fluctuation of magnetic field strength was less than
10% for > 50% area in radial direction and > 50% area in axial direction (Figure 2.4c&d).
Because the switch segment for actively-decoupling was inserted into the leg of the sample coil,
when the sample coil was switched off the secondary resonator remains on frequency (Figure
2.2d) but does not produce any observable magnetic field in the region of interest (Figure
2.4c&d).
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Figure 2.4 B1 field profiles of dual frequency RF coils. (a & b) normalized B1 field along the
diameter and axis of the dual-frequency birdcage coil. (c & d) normalized B1 field along the
diameter and axis of the actively-decoupled dual-frequency saddle coil when switched on and
off.
2.3.3 1H/19F imaging
The 90± pulse width of the single-frequency version of the saddle coil was 230/250 µs for
1

H/19F frequencies. In comparison, the 90± pulse width of the dual-frequency version of the

saddle coil was 300/310 µs for 1H/19F frequencies. Good homogeneity can be visually
appreciated from the image intensity profile of phantom images , although dual-frequency circuit
caused 50% and 25% loss of image SNR for 1H and

19

F (Figure 2.5a-c). High sensitivity

(SNR>10) was observed for the in vivo 1H and 19F imaging within the field of view (Figure 2.5df). The two imaging slices from the mouse body acquired with the dual-frequency birdcage coil
show a high level of 19F signal in the liver and heart (Figure 2.5d&e), reflecting the 19F signal of
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CE NP in the liver and the ventricular blood-pool. Figure 2.5f shows a coronal slice of “maximal
intensity projection” of the 1H and

19

F angiograms, wherein blood vessel geometry can be

evaluated clearly. Note that the voxel size for 19F imaging is greater than the diameter of mouse
blood vessels; in this case larger blood vessels (jugular veins) would yield a stronger signal in a
single voxel due to partial volume effects.

2.4 Discussion
Impedance matching at both frequencies is achieved by incorporating appropriate degrees of
freedom (number of independent variable capacitors) within the circuit, despite the added
complexity of calculating an analytical solution from the ideal coupled resonator model.
Specifically, the impedance matching at two separate frequencies embeds two equations in the
complex number domain or four equations in the real number domain. Thus, four independently
tunable capacitors are sufficient to guarantee the existence of solutions for a good matching.
It is worth mentioning that the matched quality factor (Q) measured from S11 does not
necessarily provide a useful measurement for a dual-frequency RF coil based on the coupled
resonator. The Q value of the coil is affected by losses associated with the sample coil and the
secondary LC circuit (9). In this case, alternative metrics can be exploited to assess the
performance of the dual-frequency coil, e.g., imaging sensitivity test and measurement of the
pulse width with given power and flip angle.
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Figure 2.5 Phantom and in vivo test of RF coils. Sensitivity profile of proton images of a 50 ml
tube filled with saline acquired with dual-frequency birdcage coil (a) and a single tuned surface
receive coil in conjugation with an actively-decoupled dual-frequency saddle transmission coil
(b). (c) comparison of imaging quality of single-frequency and dual-frequency versions of the
same saddle coil. 1H and

19

F images acquired with dual-frequency birdcage coil show the PFC

signal in liver (d) and cardiac blood pool (e). (f) 1H and 19F angiography show the carotid artery
and jugular vein images. Image SNR was calculated by averaging SNR in manually selected
region of interest.
For certain cases of imaging of fluorinated contrast agents, which requires an extensive field
of view for the 1H imaging portion, the actively-decoupled saddle coil can be used as a transmit
coil for

19

F imaging, and as a transmit/receive coil for 1H imaging. In this case, a constant DC
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bias is utilized to keep the volume coil on resonance for the 1H image, and thus no retuning
procedure is needed to switch between two imaging nuclei.
Finally, the limitations of coupled resonator paradigm for designing dual-frequency coils can
be considered as follows. For well separated frequencies, the frequency-dependant inductance of
the sample coil will be significantly different at two working frequencies. However, it is difficult
to implement a small copper loop inductor that has the same frequency-dependent inductance as
the sample coil, and thus it will hinder the equivalence of sample coil and secondary resonator.
The “in-phase” and “anti-phase” modes, as described previously, will not form as expected.
Therefore, the strategy of using the coupled resonator model to fabricate a dual-frequency MRI
coil is only suitable for close Larmor frequencies, e.g., 19F/1H and 13C/23Na.
In conclusion, the present work describes a generalized strategy for designing

19

F/1H dual-

frequency coils based on the coupled resonator approach. The tested birdcage and activelydecoupled saddle coil at 4.7 T, as well as previously reported solenoid coil and open coil at 3 T
(15,19), demonstrated that this coil design can be readily adapted to diverse coil structures at
different fields strengths. A unique feature of this design is that it preserves the B1 field
homogeneity of the RF coil at both resonant frequencies. By minimizing the susceptibility effect
on image co-registration, this coil design enables direct co-registration of 19F and 1H images for
localizing delivered

19

F agent. Because the size of the inductor in the secondary resonator is

much smaller than the sample coil and it is positioned distal to the sample coil to minimize
mutual uncontrolled inductive coupling between the two resonators, the secondary resonator
inductor did not induce detectable perturbations of the magnetic field of the sample coil, nor loss
of filling factor (16). Finally, the nonlinear root-seeking procedure proposed in the current work
can effectively calculate numerical solutions for the appropriate values of tunable capacitors. In
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conclusion, in view of the anticipated utility of simultaneous 1H and
potential availability of molecular imaging contrast agents with high

19

19

F imaging and the

F content this strategy

may facilitate ultimate clinical adoption of such molecular imaging approaches given the
availability of multispectral imaging systems (1).
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3 NMR physics of PFC NP
3.1 J-coupling of PFC NP
3.1.1 Background
In high resolution liquid NMR spectroscopy, there are two major mechanisms for spin-spin
interaction. The strongest one is the direct dipole-dipole interaction between nuclear spins; and
the other one is the indirect dipole-dipole interaction between nuclear spins mediated through
electron spins. The first type of interaction (which will be discussed in greater detail in the next
chapter) affects the NMR relaxation properties, (e.g., T1 and T2) of nuclear spins but does not
lead to splitting of singlet resonant peaks into multiples because this effect is usually averaged
out by fast molecular tumbling. The second type, however, generally results in peak splitting at
the level of Hz for high resolution NMR. The indirect dipole-dipole interaction is also called Jcoupling, or scalar coupling, because the coupling terms in the Hamiltonian of nuclear spins can
be described as scalars (1-2).
In a weak coupling system, in which J-coupling constant is much smaller than the chemical
shift difference among heterogeneous chemical groups, J-coupling is only related to the z
component of the spins. In liquid NMR, the J-couplings in most PFC molecules (e.g., the
coupling between CF3 and CF2, CF2Br and CF2 groups in perfluorooctylbromide (PFOB)
molecule) are weak couplings. In most MRI scanners, because the imaging subjects are usually
much larger than NMR tubes and hence pose more complicated geometry and chemical
composition, B0 shimming over a larger spatial range is significantly coarser than that in NMR
spectroscopy. For example, the typical full width at half maximal (FWHM) of a 1H (or

19

F)

spectrum for animal imaging at 4.7 T in vivo is ~100 Hz, which is an order of magnitude larger
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than the J-coupling frequency. Hence instead inducing of peak splits, J-coupling in

19

F MRI

causes amplitude modulation of 19F resonant peaks, i.e., J-modulation (2-3).
J-modulation originates from the phase difference among different peaks in a J-coupling
induced multiplet. Because of J-modulation, the regular T2 decay of

19

F nuclear spins becomes

modulated into sinusoidal oscillations, the frequency of which is dependent on the J-coupling
constant. Unlike field inhomogeneity, J-modulation is an intrinsic property associated with the
molecular structure (independent of B0 field strength) and cannot be refocused by spin echoes.
Such an oscillating behavior with regarding to the time of echo (TE) in spin echo imaging
sequences dramatically shortens the apparent T2 value and reduces the detectable signal intensity
in

19

F imaging. On the other hand however, because the J-modulated spin echo signal is

completely eliminated when TE=1/2J, this unique feature might also be employed as an imaging
approach for selectively switching on/off certain PFC signals by adjusting the TE (4).
In the present work, we aimed to study the relationship between RF bandwidth and Jcoupling modulation in

19

F MRI of PFOB NP. The chemical structure and NMR spectrum of

PFOB are shown in Figure 3.1. Because the CF3 group yields a 50% higher MR signal as
compared to other CF2 groups, it is usually chosen as the central frequency for excitation and
readout. The

19

F nuclear spins in CF3 and the adjacent CF2 form a typical “A2B3” J-coupling

system with a coupling constant of 12.3 Hz (4-6). In most practical imaging applications, Jmodulation of CF3 peak in spin echo imaging could be different from that in a simple
spectroscopic experiment because imaging RF pulses (i.e., excitation (90±) and refocusing (180±)
pulses) usually manifest relatively limited bandwidth so as to accommodate the slice selection
imaging gradients. Therefore in order to achieve consistent quantitative 19F MRI of PFOB NP it
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is important to understand the dependency of J-modulation of CF3 group in PFOB on the
bandwidth of RF pulses (7).

Figure 3.1 Chemical structure and NMR spectrum of PFOB. (a) Chemical structure of PFOB
molecule, the J-coupling constant between CF3 and the adjacent CF2 group is 12.3 Hz. (b)
Representative MR spectrum of PFOB.
3.1.2 Methods
Theoretical calculation
The Hamiltonian of the subsystem consisting of CF3 and CF2 groups in PFOB molecule can
be written as
ߗ = ܪிଶ ሺܫ௭ଵ + ܫ௭ଶ ሻ + ߗிଷ ሺܫ௭ଷ + ܫ௭ସ + ܫ௭ହ ሻ + 2ߨܬሺܫ௭ଵ ܫ௭ଷ + ܫ௭ଵ ܫ௭ସ + ܫ௭ଵ ܫ௭ହ + ܫ௭ଶ ܫ௭ଷ + ܫ௭ଶ ܫ௭ସ +

ݖܫ2ݖܫ5,

[1]

where ܫ௭ ’s are the z-component of the angular moment of

19

F nuclear spins , ߗ’s denote the

chemical shift for each group, and  ܬis the coupling constant between two groups which is 12.3
Hz in PFOB. The initial state of this five spin sub-system, in the form of density matrix, before
any RF pulses are played out is
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ߩ = ܫ௭ଵ + ܫ௭ଶ + ܫ௭ଷ + ܫ௭ସ + ܫ௭ହ .

[2]

For RF pulses with finite bandwidth and centered at CF3 frequency, the quantum operator
format of a 90± pulse along x axis is
ഏ

గ

ഏ

ഏ

ഏ

ഏ

ܴ௫ ቀ ቁ = ݁ ି మ ூೣభ ⊗ ݁ ି మ ூೣమ ⊗ ݁ ି మ ூೣయ ⊗ ݁ ି మ ூೣర ⊗ ݁ ି మ ூೣఱ ,

[3]

ଶ

where ܫ௫ ’s are the x-component of angular moment of

19

F nuclear spins, ⊗ denotes outer

product, and ݂ = ߴሺܨܥ2ሻ/ߴሺܨܥ3) is the flip angle ratio between CF2 and CF3 group caused by
the power drop down at CF2 peak from the central frequency due to the limited RF bandwidth.
Similarly, the operator format of a 180± refocusing pulse along x axis is,
ܴ௫ ሺߨሻ = ݁ ିగூೣభ ⊗ ݁ ିగூೣమ ⊗ ݁ ିగூೣయ ⊗ ݁ ିగூೣర ⊗ ݁ ିగூೣఱ ,

[4]

where ݂ factor is identical to that in 90± pulses, which is in agreement with the RF setting of our
Varian small animal imaging system.
Applying the Schrodinger equation, the operator describing the time evolution of a
quantum state over time  ݐcan be written as
ܷሺݐሻ = ݁ ି௧ு ,

[5]

where  ܪis the Hamiltonian of the system. Therefore, in a regular spin echo imaging sequence,
the density matrix of the final state of the coupled CF3-CF2 subsystem can be calculated as
்ா

்ா

గ

்ா

்ா

గ

ߩ = [ܷ ቀ ଶ ቁ ∙ ܴ௫ ሺߨሻ ⋅ ܷ ቀ ଶ ቁ ⋅ ܴ௫ ቀ ଶ ቁ]ற ⋅ ߩ ⋅ ܷ ቀ ଶ ቁ ⋅ ܴ௫ ሺߨሻ ⋅ ܷ ቀ ଶ ቁ ⋅ ܴ௫ ቀ ଶ ቁ.

[6]

Here we do not consider the regular T2 decay in the transverse plane. To account for T2 decay,
we only need to multiply the final state function by a scalar ݁ ି்ா/்ଶ .
As the last step in the NMR/MRI experiment, when we measure magnetization in the
transverse plane, the final signal intensity of CF3 in a spin echo sequence can be calculated by
taking trace of the product of density matrix with the transverse angular momentum operator:
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ܵ = ݁ ି்ா/்ଶ ⋅ ܶߩ[ݎ ⋅ ሺܫ௫ଷ + ܫ௫ସ + ܫ௫ହ ሻ].

[7]

All calculations were performed analytically in a custom-designed program written in
Mathematica (Wolfram, USA).
Experimental investigation of J-modulation in 19F MRI
High resolution NMR spectroscopy of PFOB NP was performed at a 7T Varian spectrometer.
The sample was set spinning on an air cushion to improve B0 field homogeneity and a regular
single pulse spectrum was acquired with TR = 10 s. To validate J-modulation, we performed spin
echo spectroscopy of a 50 ml test tube containing 1% PFOB NP at Varian 4.7 T small animal
scanner using a custom-built solenoid RF coil. In this experiment, TR=10 s, and TE was varied
from 1 ms to 300 ms to capture the J-modulation profile of CF3 peak. MR spectroscopic
quantification of PFOB content in the phantom was performed using an identical spin echo
sequence with another sample of CE NP as an external reference. During the experiments, the
bandwidths of both the 90± and 180± RF pulses were changed to examine the dependency of Jmodulation on RF bandwidth.
Application of J-modulation on selective imaging
We performed a phantom study to demonstrate the use of J-modulation for selective 19F MRI
where PFOB was intentionally suppressed while a different type of PFC NP was selected for
imaging. We filled an NMR tube with CE NP and inserted it into a larger glass bottle (1 cm in
diameter). The empty space between two containers was filled with PFOB NP. Spin echo
imaging in the transverse plane of the phantom was performed at 4.7 T with TR = 2 s, TE=10
and 44 ms respectively, voxel size = 0.2 mm × 0.2 mm × 2 mm. The corresponding PFOB
spectroscopy also was acquired using a spin echo spectroscopy sequence with the identical
TR/TE values.
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Figure 3.2 Theoretically calculated J-modulation profile of CF3 peak in PFOB molecule for
different RF bandwidth. Narrow band excitation RF pulse reduces the effect of J-coupling
according to theoretical calculation.
3.1.3 Results
Theoretical calculation of the J-modulation profile for different RF bandwidths (݂ value) is
presented in Figure 3.2. Three representative scenarios were considered. (1) Extremely narrow
excitation/refocusing bandwidth: RF power was only transmitted to the CF3 group while CF2
group was not affected, and PFOB did not exhibit any J-modulation induced amplitude
oscillation in this case. (2) Extreme wide band excitation/refocusing: both the CF2 and CF3
groups were fully excited and refocused. Maximal J-modulation was observed for the CF3 peak
in this case. It is notable that at certain discrete points, when ܶ = ܧሺ2݊ + 1ሻ/2 > ݊( ܬ0 is an
integer), the signal intensity of the CF3 peak was completely suppressed by J-modulation. (3)
With the use of a medium RF bandwidth for excitation/refocusing, both the oscillation amplitude
and the frequency of J-modulation were decreased.
Under conditions of high resolution MR spectroscopy (Figure 3.3a), we observed that Jcoupling caused splitting of the CF3 singlet into a triplet, as expected. The frequency difference
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between two adjacent peaks in the triplet was  ܬand the absolute intensity ratio among these
peaks was approximately 1:2:1. By comparison, in low resolution spin echo spectroscopy, we
observed that the intensity of the CF3 peak was highly modulated when we varied TE. However,
if the RF bandwidth was narrowed, or if all of the RF pulses were highly selective, the CF3 peak
did not exhibit any J-modulation effect (Figure 3.3b&c), which accorded with our theoretical
calculation. The quantification of PFOB concentration with the use of a CE NP standard varied
with both TE and RF pulse width (Figure 3.4). This result suggests that

19

F spectroscopic

quantification is highly dependent on the choice of TE and pulse width. Therefore a shorter TE
and a fixed choice of RF bandwidth should always be preferable in order to achieve consistent
quantification.
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Figure 3.3 NMR spectra of PFOB under different resolution and RF bandwidth. (a) High
resolution NMR spectroscopy of the CF3 peak revealed peak split due to J-coupling. (b & c) Jmodulation under nonselective and selective RF pulses.
To demonstrate the utility of J-modulation to suppress background PFOB signal, from the
PFOB spectroscopy, we suggest that a choice of TE = 44 ms might lead to a much lower CF3
signal intensity as compared with other peaks, and a total elimination of PFOB background when
imaging the other PFC component (which here is CE) selectively (Figure 3.5).

48

Figure 3.4 J-coupling effect on the acquired 19F MR signal from a PFOB phantom relative to that
of a CE standard. The relative signal strength of PFOB, reflecting 19F MRI measured “quantity”
of PFOB, varied at different excitation pulse width and TE, suggesting fixed pulse width (or
bandwidth in the frequency domain) is required for quantitative PFOB MR spectroscopy.

Figure 3.5 Images (and correpsonding spectra) of PFOB and CE with nonselective excitation.
The center disk corresponds to CE while the outer circle rings correspond to the chemical shift of
the CF3 peak from PFOB.
3.1.4 Conclusion
In this section, we have proposed a general theoretical framework for evaluating Jmodulation of PFOB in MR spectroscopy and imaging. We incorporated into our model the
effect of finite RF bandwidth and theoretically proved that narrow band excitation/refocusing
could reduce or even eliminate J-modulation effect in a spin echo sequence. High resolution and
low resolution spectroscopy of PFOB NP confirmed the J-coupling induced peak spliting and J49

modulation of the CF3 group. Furthermore, by carefully choosing the TE value in a spin echo
imaging experiment, we could selectively switch on/off signal from the CF3 peak in PFOB.

3.2 Oxygenation effect on the absolute quantification of 19F MRI
3.2.1 Background
The unique 19F MR signature of PFC NP has been exploited for conducting quantitative MRI
because practically no background signal emanates from physiological tissue (8). However, the
spin-lattice relaxation time (T1) of PFC emulsion is inversely correlated with oxygen
concentration, which varies in different tissues (e.g., in tumor and artery). Therefore, it is
necessary to choose in vivo acquisition parameters that minimize the oxygenation effect on
quantitative

19

F MRI-determined regional concentrations of PFC NP (9). Additionally,

acquisition parameters should be optimized to maximize the SNR, which is a general concern for
in vivo

19

F MR applications. In this study, the effect of TR and TE on the accuracy of

quantitative 19F MR were evaluated by mathematical simulation followed by in vivo validation.
3.2.2 Methods
Effect of oxygenation on 19F T1
In vitro measurement of

19

F R1 as a function of pO2 was acquired at selected O2

concentrations (ranging from 0% to 100% O2 balanced with N2) by bubbling a gas mixture into a
neat PFOB sample, a PFOB NP sample, a neat CE sample, and a CE NP sample for 30 minutes
at room temperature. Experiments were performed on a 4.7 Varian small animal scanner, and 19F
T1 measurements were made using inversion recovery spectroscopy with TR=10 s, and 10
inversion delays (TI) ranging from 3 ms to 5 s.
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Simulation
Starting from the Bloch equations, simulations of spin echo spectroscopy sequences were
preformed in Matlab (Mathworks, Inc.). First, the expected

19

F signal intensity as a function of

TR and TE was simulated to assess SNR. Subsequently, two simulations were conducted by
setting the

19

F T1 relaxation time of PFC NP to 0.9 s, thereby simulating normoxic conditions

(21% [O2]), and 0.6 s, simulating hyperoxic conditions (100% [O2]) (10). The calculated
oxygenation-induced quantification error was plotted as a function of TR and TE. The T2 for all
simulations was set to be 0.3 s. The quantification fidelity was defined as Snormoxia/Shyperoxia, or the
ratio of signal intensity between normoxia and hyperoxia.
In vivo 19F MRI/S
MR experiments were performed on an 11.7T Varian INOVA MR system. Three
C57/BL6 mice under room air ventilation were intravenously injected with 20% v/v CE NP
emulsion (4 mL/Kg) through the tail vein. At 3-hour post injection, mice were anesthetized with
a standard dose of ketamine/xylazine. A solenoid 19F coil was placed on the right rear leg of the
mice for in vivo imaging. A 1H scout image of the leg was first acquired to visualize the
anatomy. Subsequently, a T1-weighted spin-echo

19

F image (TR = 350 ms, TE = 16 ms) was

acquired to visually examine the 19F signal intensity, followed by 19F T1 measurement using an
inversion recovery spin-echo sequence (TR = 5 s, TI increases from 5 ms to 1.8 s with 0.2 s
interval). Finally, quantification of regional PFC NP concentration was conducted with a
previously reported

19

F MR spin-echo spectroscopic method (TR = 0.3, 2.0, and 3.0 s) using

trifluoroacetic acid (TFA) sealed in a pipette tip as a reference standard. Two sets of images were
acquired for each mouse when breathing room air (normoxia condition) or 100% oxygen
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(hyperoxia condition). Other parameters for 19F imaging were: RF excitation bandwidth, 350 Hz;
number of average, 128; in plane resolution: 1mm µ 1mm; slice thickness: whole projection.
3.2.3 Results

Figure 3.6 Longitudinal relaxation rate of PFC NP and neat PFC liquid as a function of pO2 at
4.7 T.
R1 (longitudinal relaxation rate: 1/T1) of CE NP and different chemical groups in PFOB as a
function of oxygen tension are summarized in (Figure 3.6). R1 of neat PFC and PFC NP were
dependent on the oxygenation level, and the slope for the neat form was very close to that for the
NP form of the same PFC component. Moreover, the CF3 and CF2Br group in PFOB also
responded to oxygenation in a similar manner.
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Figure 3.7 The relation between

19

F quantification and TR/TE (simulation result). (a)

Measurement fidelity (the ratio between

19

F intensity under normoxia and hyperoxia) of the

simulated 19F signal intensity for T1 = 0.9 s (normoxia) and 0.6 s (hyperoxia) at various TR. T2
was set to be 0.3 s. (b) The normalized SNR of 19F MRI as a function of TR and TE within the
same data acquisition time. T1 was set to be 0.9 s and T2 was set to be 0.3 s.

Figure 3.8 Dependence of 19F quantification on TR (in vivo result). (a) High resolution 1H image
shows the position of the mouse leg and a TFA calibration standard (arrows). (b and c) T1
weighted 19F image of mouse leg when the animal was under normoxia (b) or hyperoxia (c). (d)
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Quantified

19

F T1 of CE NP in mouse leg under normoxia and hyperoxia. (e) T1 and

quantification difference (in percentage) of CE NP using different TR.
Figure 3.7 shows the simulation result. The optimal parameter for achieving the highest SNR
is TR≈1.5*T1. Additionally, the quantification difference between normoxia and hyperoxia
conditions was less than 5% when TR ≥ 3 *T1. Figure 3.8 shows in vivo 19F MR result of mouse
leg after PFC NP treatment. T1-weighted 19F signal in mouse leg under normoxia was apparently
lower than that under hyperoxia. Correspondingly, a ~50% decrease of

19

F T1 was observed

from normoxia to hyperoxia conditions. Because of the oxygenation effect on

19

F T1, a more

than 100% quantification error of PFC NP concentration was observed when TR = 0.3 s.
However, the quantification error was insignificant when TR = 3 s, i.e., ≥ 3*T1.
3.2.4 Discussion
We demonstrated that

19

F MRI-determined PFC NP quantity was not sensitive to local

oxygenation when TR> 3*T1. Results from mathematical simulations were in agreement with
those determined from in vivo experiments. In clinical situations, tissue oxygenation is
inhomogeneous in various organs such as tumors. Thus, a long TR (over 3 times T1) should be
used for in vivo studies to guarantee that

19

F MRI-determined PFC concentration accurately

reflects the 19F spin-density.

3.3 “Multi-chromatic” 19F MRI
3.3.1 Background
Conventional 1H MRI only affords a mono-chromatic readout of a single biomarker because
water exhibits a single resonant frequency inside an external magnet. When the need for
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simultaneous characterization of multiple biomarkers arises, alternative imaging approaches
must be employed to generate multi-chromatic images to distinguish different types of
biochemical targets. With unique 19F signals emanating from the core, PFC NPs enable a direct
and quantitative readout of biomarkers with the use of 19F MRI. In contrast to organic molecules
that are rich in proton atoms, PFCs exhibit a widely spread chemical shift (~100 ppm) (11).
Recently, Sirinvias et al demonstrated the feasibility of manufacturing functional nanoparticles
from five different PFC species (12). Because different PFC molecules manifest distinct

19

F

spectroscopic signatures, detection and identification of each PFC could be realized in one
sample containing multiple PFCs. The feasibility of imaging two PFC components individually
was first discussed by Mason et al, even though the PFC itself was not functionalized as a
targeting contrast agent in their study (2). The first selective bi-chromatic imaging for two
different PFCs as a molecular contrast agent was demonstrated ex vivo by Caruthers et al (13).
However, the technical requirement for imaging multiple (>3) PFC species and the potential
biomedical application of multi-chromatic 19F MRI with PFC NPs demands further experimental
validation.
3.3.2 Methods
Multi-chromatic 19F MRI with extreme narrow RF bandwidth
All NMR spectroscopy and MRI in this study were performed on an 11.7 T Varian
scanner. For phantom imaging, five NMR tubes were filled with five previously studied neat
PFC components, i.e., Perfluorooctyl-Bromide (C8F13Br, PFOB), Perfluorodecalin (C10F18,
PFD),

Perfluoro-12-Crown-4-Ether

(C8F16O4,

PF-12-CE),

Perfluoro-15-Crown-5-Ether

(C10F20O5, PF-15-CE or CE) and Perfluorooctane (C8F18, PFO), respectively. NMR spectra of
each of these PFCs were acquired using a regular single pulse spectroscopy sequence with a
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broad excitation and receiving bandwidth of 30 kHz and 40 kHz respectively. After acquiring the
NMR spectra, one resonant peak of each PFC was chosen as the “signature frequency,” which
could be selectively imaged for

19

F multi-chromatic MRI. One chemical shift was selected as a

signature frequency based on the following criteria: (1) the signature frequency of one PFC
should not overlap with any resonant frequencies from any other PFCs; (2) the separation
between any two selected signature frequencies should be as wide as possible; (3) if multiple
peaks exist and meet criteria (1) and (2), the one that exhibits the strongest NMR signal should
be chosen. Finally, the signature frequency of each of PFC was determined to be: 26.8 ppm for
PFOB, -23.9 ppm for PFD, 1.7 ppm for PF-12-CE, 0 ppm for PF-15-CE, and 17.5 ppm for PFO,
respectively.
For multi-chromatic imaging, all five NMR tubes containing the aforementioned PFC
species were placed inside a 50 ml tube filled with DI water. A fast spin echo sequence (FSE)
was employed to identify each PFC separately by selectively exciting and refocusing at the
signature frequencies. In order to realize complete separation and avoid potential cross talk
among different PFCs, we employed a sinc shape pulse with 8 ms duration for both 90± and 180±
pulses in the FSE sequence. The frequency bandwidth of such a long pulse was as narrow as 700
Hz, which is sufficient to distinguish between the closest spaced signature frequencies of all five
PFCs. Other imaging parameters were: echo train length = 8, TR = 2 s, TE = 20 ms, in plane
resolution = 0.25 × 0.25 mm, slice thickness = 1 cm. After 19F MRI, transmit and receive offset
was switched to 1H frequency and a regular gradient echo sequence was employed to acquire a
1

H image to visualize the structure of the phantom. The parameters for 1H MRI were TR = 100

ms, TE = 5 ms, in plane resolution = 0.25 × 0.25 mm, slice thickness = 1 cm, flip angle = 30±.
Multi-chromatic MRI in macrophage cellular imaging
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RAW 267.3 macrophage cells (n=3 for each group) were cultured in gelatin coated T75
flask to reach around 80% confluence, and a mixture of CE NP and PFOB NP was added to the
culture media at concentrations of 2, 5, 10 and 20 µl/ml. The mixed PFC NP contained 75%
volume fraction of plain PFOB NP and 25% of plain CE NP. After 2-hour incubation, flasks
were washed with PBS for 3 times and then cells were counted, harvested and spun down to
form loose pellets. 19F spectroscopic quantification was performed for all cell samples with 10 µl
trifluoroacetic acid (TFA, 1% volume concentration) sealed in a pipette tip as an external
standard. Multi-chromatic imaging of CE NP, PFOB NP and TFA standard was performed using
the protocol described previously.
In vivo demonstration of multi-chromatic MRI
A Swiss Webster mouse was anesthetized with ketamine/xylazine. The left leg of the
mouse was secured to the inner surface of a custom-built 19F/1H dual frequency solenoid coil. 10
µl of CE NP were injected into the foot pad of the left leg while 50 µl of PFOB NP was injected
intramuscularly into the calf. A 1H gradient echo image was firstly acquired to visualize the
anatomy of the leg, with TR = 100 ms, TE = 5 ms, thickness = 1 mm, resolution = 0.5 mm× 0.5
mm. Without retuning the dual-frequency probe,

19

F spectroscopy was acquired at the exact

same position over the whole leg. A receiving bandwidth of 40 KHz was used to cover the
widely spread chemical shifts of PFOB. By selectively exciting and receiving at the signature
frequency of CE and PFOB as described in previous sections, multi-chromatic

19

F MRI was

performed to map the distribution of both PFC NPs. The detailed imaging parameters were as
follows: echo train length = 8, TR= 2 s, TE = 20 ms, in plane resolution = 1 mm µ 1 mm, slice
thickness = 2 mm.
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3.3.3 Results
NMR spectra of PFOB, PFD, PF-12-CE, PF-15-CE and PFO are shown in Figure 3.9.
Signature frequencies selected for

19

F MRI were marked and color coded to represent the

different PFCs. The closest signature frequencies between two PFCs were from PF-15-CE and
PF-12-CE, which were only 800 Hz apart. Because of the extremely narrow excitation
bandwidth (700 Hz) used in this study, we were able to identify and image each of the PFC
species individually. MRI images of all PFC components (Figure 3.10), normalized to the
maximal intensity within the region of interest (ROI), were color coded with the same color as
marked in the corresponding spectra. Because we always placed the excitation and readout
central frequency at the signature frequency of the PFC that we aimed to image, chemical shift
artifact was not present in the

19

F images and all

19

F images automatically co-registered well

with the 1H background image. Moreover, the J-coupling effect was not present in these images
because both the multi-echo MRI paradigms and the selective excitation suppress the indirect
coupling between multiple chemical groups within a PFC molecule.
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Figure 3.9 MR spectra of five PFC components. One signature frequency (color coded) of each
PFC component was selected for multi-chromatic 19F MRI

Figure 3.10 Multi-chromatic 19F MRI of a phantom containing five PFC components.
In vivo result
Two imaging slices from the mouse leg (Figure 3.11) revealed distinct localizations of
CE NP and PFOB NP representing different injection schemes. Good separation between two
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PFC NPs was achieved in the 19F image, as a demonstration of the feasibility for multi-chromatic
19

F in vivo.

Figure 3.11 In vivo multi-chromatic 19F MRI of mouse leg. (Blue: CE, Yellow: PFOB)

Figure 3.12 Multi-chromatic 19F MRI for macrophage cellular imaging. (a) Multi-chromatic 19F
of macrophage pellet. (b) Quantification of both PFOB and CE NP at different incubation dose.
(c) Internalized concentration of PFOB and CE NP are linearly correlated.
Cellular imaging result
60

Representative multi-chromatic images and spectroscopic quantification are shown in
Figure 3.12a&b. The TFA standard and internalized CE and PFOB NP in cell pellet are
visualized individually in

19

F MRI. The

19

F quantification revealed an increase of retained NP

concentration in cells as the incubation concentration increased. However, there was no
significant difference between the 10 µl/ml and 20µl/ml groups suggesting that macrophages
were saturated at the high dose of PFC NP. As shown in Figure 3.12c, the retained concentration
of CE NP was linearly correlated with PFOB NP and the ratio between them was identical to that
in the NP mixture used for incubation (1:3). These results confirmed that macrophage cells
endocytosed both NPs in the same manner if they possessed identical size and surface charge.
The specific chemical contents inside PFC NP did not seem to affect the cellular update in
macrophages.
3.3.4 Discussion
In this work, we have proposed and verified a paradigm for multi-chromatic

19

F MRI

imaging. We validated this technique in a phantom containing five different PFC components,
each one of which could be imaged via MRI individually. Using multi-chromatic

19

F MRI as a

tool, we investigated the cellular update of two different PFC NPs in macrophages. We
quantitatively defined the saturation level of macrophage endocytosis for PFC NP and confirmed
that PFC component did not affect the internalization of these particles into cells. We also
demonstrated our multi-chromatic

19

F MRI technique in vivo for visualizing two different

intramuscularly injected PFC NPs.
Currently, multiple clinical and preclinical targeting mechanisms have been proved to be
effective in vivo using functionalized PFC NP and associated imaging techniques. These PFC
NPs with targeting ligands actively bind to various biomarkers in cancer and cardiovascular
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disease, such as αvβ3 (14) and αvβ5 (15) in rabbit tumor and atherosclerotic angiogenesis (16),
fibrin (17) and thrombin during acute coagulation (18), and VCAM during microvascular
inflammation of chronic renal disease (8). Multi-chromatic

19

F MRI could provide a promising

imaging approach for registering multiple disease biomarkers simultaneously and investigating
the pathophysiological interaction between different disease epitopes.
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4 Paramagnetic relaxation enhancement of PFC NP
4.1 Introduction
Molecular imaging with ligand-targeted

19

F nanoparticles (NP) is an emerging diagnostic

approach for magnetic resonance imaging (MRI) and spectroscopic detection and classification
of various diseases (1). When combined with conventional 1H MRI,

19

F MRI yields high

resolution anatomic information and enables spectroscopic quantification of disease biomarkers
(2-4). Among the available

19

F MR contrast agents, perfluorocarbon (PFC) NPs have shown

potential for imaging of cancer and atherosclerosis both as vehicles of paramagnetic agents (5-7)
and as intrinsic fluorine signaling entities (8-11). The high concentration of 19F in PFC NP, the
lack of innate background

19

F signal in tissues, and the demonstrated safety of the basic agent

(12), position targeted PFC NP as a promising contrast agent for molecular MRI with significant
translational potential (4).
However, the

19

F MR signal intensity of PFC NP is limited by two factors that impose

hurdles for clinical utilization. First, despite its high signal nucleus, the total amount of 19F that
can be injected still is much less than the natural abundance of 1H in tissues (13), which
challenges signal-to-noise requirements in clinical imaging scenarios. Second, the long 19F T1 for
PFC NP, which is roughly equivalent to that of neat PFC liquid, challenges efficient data
acquisition (14). Lee et al originally reported that Gd can function as a relaxation agent for
fluorine under certain circumstances (15). Recently, Neubauer et al showed that coating PFC NP
with paramagnetic Gd chelates markedly accelerates relaxation of PFC molecules and thus is
indeed useful for enhancing the 19F signal within the limited timeframe typically available for in
vivo imaging (16). Nevertheless, in order to better facilitate its further application in vivo and
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provide guidance for the chemical synthesis of this type of paramagnetic NP, a first-principle
analysis of the special relaxation properties of

19

F spins in paramagnetic PFC NP is of great

importance.
Previous investigations of water translational motion used models of pure outer-sphere
relaxation to study spin dynamics of 1H that are separated from free radicals by lipid bilayer
membranes, silicon surfaces, or protein surfaces (17-19). In this report, we suggest similar
applications to the specific case of assessing the paramagnetic relaxation enhancement of

19

F

nuclei in the core of PFC NP. To do so, the Solomon, Bloembergen and Morgan theory (SBM
theory) (20-22) was applied to the outer-sphere interaction between

19

F spins and Gd ions that

are separated by lipid monolayer. The modeling framework for the paramagnetic relaxation
enhancement recognizes that at clinical field strengths the zero field split effect can be neglected
(23).
For aqueous solutions, the total paramagnetic relaxation enhancement is contributed by two
compartments: inner-sphere and outer-sphere relaxation (24). The inner-sphere relaxation
requires a direct coupling interaction between the imaging/signaling molecule (e.g., water for 1H
MRI, or PFC for

19

F MRI) and a paramagnetic ion (e.g., Gd3+) over a short time interval to

facilitate energy transfer. In contrast, outer-sphere relaxation is caused by the translational
diffusion of the imaging molecule around the paramagnetic center without the need of direct
binding (25-27). For most paramagnetic contrast agents, the inner-sphere relaxation (i.e., the
direct binding effect) is the dominant mechanism for relaxation enhancement. However, innersphere relaxation does not exist in PFC NP because the PFC core is well separated from surface
Gd ions by a lipid/surfactant monolayer (Fig. 4.1a). The relaxation enhancement in this case is
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caused solely by the diffusion of encapsulated PFC molecules to the proximity of Gd on the
outer lipid monolayer surface through an outer-sphere relaxation mechanism.
Based on this physical model, we sought to apply these observations to elucidate the
interaction of a living cell with such a NP system after internalization into endosomal
compartments, and to detect the actual break down of the particle into its component parts (28).
We show that endocytosis results in an alteration in

19

F relaxation as Gd chelates are stripped

from the NP surface, thus returning the 19F T1 to its native relaxation state without paramagnetic
relaxation enhancement. These interactions reveal a “19F relaxation switch” phenomenon that can
track the activity of the endosome as it degrades the ingested material, which might be of use
experimentally for dynamic monitoring of the function of such intracellular organelles.

4.2 Theory
4.2.1 Boundary conditions and physical parameters of PFC NP with Gd coating
The structure of paramagnetic PFC NP is illustrated in Figure. 4.1a. The NPs are the PFC
droplets in a PFC-water emulsion system and exhibit diameters ranging 100-300 nm. Because
the hydrophilic head groups of the lipid monolayer establish an ultimate boundary against the
translational diffusion of PFC molecules toward the Gd on the outer surface, we follow the
treatment in (29) to introduce the concept “distance d of closest approach”, where d is defined as
the smallest distance between a PFC molecule in the core of the NP and the Gd ion layer on the
surface of NP. Practically, d is a parameter determined by the length of the linker attaching the
Gd chelate to the hydrophilic surface of the lipid layer, as well as by the maximal penetration
depth of PFC molecule into the hydrophobic tails of the lipid layer (5, 19). To simplify the
modeling, the diffusion of the PFC molecule is assumed to be unrestricted with a diffusion
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coefficient D as long as its distance to the Gd layer is greater than d. Finally, the Gd chelates on
the lipid layer are assumed to be randomly distributed and the Gd concentration is described by a
Gd/lipid molar ratio [Gd]. These physical properties of NP influence the enhancement of
longitudinal relaxation rate ∆R1 of PFC NP (30), which is defined as the difference between R1
(R1=1/T1) of Gd-coated NP and non-Gd-coated NP,

∆R1 = R1 ( NP withGd ) − R1 ( NP without Gd ).

[1]

Figure 4.1 Chemical structure of paramagnetic PFC NP. (a) Illustration of configuration of
paramagnetic PFC NP. Direct contact between Gd ions and PFC molecules is prevented by the
lipid monolayer. (b) and (c), Chemical structure and NMR spectra of CE and PFOB. (d) and (e),
Chemical structure of DTPA-BOA-Gd and DOTA-PE-Gd shows the longer linker chain of
DOTA-PE-Gd as compared with DTPA-BOA-Gd.
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4.2.2 Theoretical calculation of paramagnetic relaxation enhancement in PFC NP
Paramagnetic relaxation enhancement of PFC NP is caused by the fluctuation of dipolar

r
r
energy between the electron spin S from the Gd ion and the nuclear spin I from the PFC
molecule (21). Specifically, this dipolar interaction Hamiltonian takes the following form
H IS =

r r r r r r
h 2γ I γ S
1
[3( I • r )( S • r ) − I • S ] = F0 A0 [ I Z S Z − ( I + S − + I − S + )] + F1 A1 ( I + S Z + I Z S + ) +
3
rIS
4
,

*
1 1

[2]

*

F A ( I − S Z + I Z S − ) + F2 A2 I + S + + F2 A2 I − S − ]
in which F0 = (1 − 3cos 2 θ ) / rIS 3 , F1 = sin θ cos θ eiϕ / rIS 3 , and F2 = sin 2 θ e 2 iϕ / rIS 3 represent three
components of the dipolar interaction that are proportional to the second rank spherical
harmonics; γ I and γ S are the gyromagnetic ratios for relevant nuclear and electron spin; and
A0 = h 2γ I γ S ,

A1 = −3 / 2 h 2γ I γ S and A2 = −3 / 4 h 2γ I γ S are three real constants. Based on the

r
theoretical treatment proposed by Solomon (21), the relaxation enhancement of I contributed by
a single nuclear-electron spin pair can be written as
∆r1 = h 2γ I 2γ S 2 S ( S + 1)[

1
3
3
J 0, pair (ω I − ω S ) + J1, pair (ω I ) + J 2, pair (ω I + ω S )] ,
12
2
4

[3]

in which J q , pair ( q = 0,1, 2) is the spectral density of the correlation function for the qth
component of dipolar interaction Fq ; S is the quantum number for the total electron spin; ωI
and ωS are the Larmor precession angular frequencies for nuclear and electron spin,
respectively. Specifically, the spectral density for correlation function of the qth component of
the dipolar interaction is defined as (29)
∞

J q , pair (ω ) =

∫ F (t ) F
q

q

*

(t + τ ) e − iωτ dτ = F[ Fq (t ) Fq* (t + τ )] ,

−∞
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[4]

in which F represents Fourier transform, and the average is taken over t with the τ and ω
forming a Fourier transform pair.
The magnitude of a specific component of dipolar interaction Fq is modulated by two
factors: 1) for a PFC molecule, the diffusion-induced change of the relative distance and angle

θ , ϕ between a nuclear-electron spin pair (31); and 2) the propensity of the anchored Gd chelate
on the lipid surface to undergo vibration, reorientation of the linker chain, and lateral diffusion
across the membrane that might modulate nuclear-electron interactions (32). In the present study,
the second mechanism is negligible because the lateral diffusion of Gd chelate on the lipid
surface is restricted and much slower than is the Brownian diffusion of PFC inside the NP (32).
Thus, we assume that the diffusion of PFC molecules represents the major source for the
fluctuation of dipolar interactions. The probability for a single PFC molecule to move from

ur
uur
position R0 to R after time τ was modeled as a Gaussian function (33)
ur uur

2

( R − R0 )
ur uur
−
−3/2
P(τ , R; R0 ) = (4π Dτ ) e 4 Dτ ,

[5]

where D is the diffusion coefficient of PFC molecule.
The coordinate system used in Eq. 2 to define Fq is centered at the electron spin. The zaxis is along the direction of the external magnetic field. To facilitate modeling in a symmetric
way, an alternative coordinate system, the “NP reference frame”, was defined with the origin
positioned at the center of the NP and the z-axis aligned in the direction of external field. The
expression of Fq in the NP reference frame then depends on the position of the electron spin.
Taking into account all possible positions of a nuclear spin interacting with a single electron spin
at position (θGd , ϕGd ) on the surface of NP, the spectral density can be rewritten in the following
form
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r r
r
r r r
4
J q (θ Gd , ϕ Gd , ω ) = F [ ∫∫ P (τ , R; R0 ) Fq (θ Gd , ϕ Gd , R0 ) Fq * (θ Gd , ϕ Gd , R ) dRdR0 ] / π r 3 ,
3

[6]

where the integral is taken over the space inside the NP. Considering the spherical symmetry of
the NP and summing up the contribution from all the Gd ions and following the calculation
proposed by Abragam (29), the spectral densities including all the electron spins are in the form
of

J q ,total (ω ) =

∑

∞

J q (θGd , ϕGd , ω ) = Cq

Gd Positions

∞

J (kx)
[Gd ]
Dk 3
d
[ 5/23/2 (1 − )dx]2 dk ,
2
2 2 ∫
∫
r 0 ω + ( Dk ) d x
x

[7]

in which J 5/2 (kx) is the Bessel function and Cq ’s are real constants with the relationship

C0 : C1 : C2 = 6 :1: 4 due to normalization factors for Fq ’s (21). The absolute value of Cq ’s is
determined by the separation of surface Gd ions (16). Because the gyromagnetic ratio of the
electron spin is more than 1000x greater than that of the nuclear spin, both ωI − ωS and ωI + ωS
would be much greater than ωI . Careful examination reveals that

J 0,total (ω I − ω S ) and

J 2,total (ω I + ω S ) are negligible compared to J1,total (ω I ) , so that the final form for the relaxation

enhancement for the NP is:
∞

∞

J (kx)
3 2 2 2
[Gd ]
Dk 3
d
∆R1 = h γ I γ S S ( S + 1)C1
[ 5/23/2 (1 − )dx]2 dk .
2
2 2 ∫
∫
2
r 0 ωI + ( Dk ) d x
x

[8]

Thus, enhanced relaxation is due primarily to the dipolar interaction terms I + S Z and I Z S +
corresponding to q = 1 in Eq. 2.
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4.3 Material and Methods
4.3.1 NP formulation and characterization
The actual PFC NP emulsion is composed of 20% (v/v) of perfluoro-15-crown-5 ether
(CE; Exfluor Research Corp., USA) or perfluorooctylbromide (PFOB; Minnesota Manufacturing
and Mining, USA), a 2.0% (w/v) surfactant commixture, and 1.7% (w/v) glycerin, with water
comprising the balance. CE has twenty chemically equivalent fluorine atoms and produces a
single

19

F NMR peak (Figure 4.1b); PFOB exhibits seven different chemical shifts and J-

coupling splitting (Figure 4.1c). For incorporating the paramagnetic ions, the surfactant
commixture is comprised of lecithin (Avanti Polar Lipids Inc, USA), dipalmitoylphosphatidylethanolamine (Avanti Polar Lipids Inc., USA) and two possible lipophilic
gadolinium chelates, namely Gd-DTPA-BOA (Gateway Chemical Technologies, USA) and GdDOTA-PE (Dow Chemical Co., USA) with the concentration of 30 mol% Gd. The relevant
difference between the two Gd chelates is that Gd-DTPA-BOA has shorter linker arm length
than does Gd-DOTA-PE, which causes the DTPA-BOA linked Gd to abut the surface of the NP
(34) (Figure 4.1d and e), whereas the DOTA-PE linked Gd is more remote. The particle sizes
were determined at room temperature with a dynamic light scattering particle sizer (Brookhaven
Instruments Corp., USA). Diffusion coefficients of the neat liquid CE and PFOB were measured
at room temperature with a pulsed gradient spin echo sequence on a 4.7 T Varian INOVA smallbore imaging system (35).

4.3.2 Monte-Carlo simulation
To confirm the non-uniform field distribution in the PFC core, a Monte-Carlo simulation
of the Gd-induced magnetic field inside the PFC NP was performed. We chose 1,800 randomly
sampled points on the surface of NP (diameter, 200 nm) as the locations for Gd ions, and set the
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distance between Gd to the surface of NP at 2 nm. For each point inside the NP, the contributions
from all dipolar magnetic fields produced by Gd ions were summed. In the simulation, the
magnitude of magnetizations of Gd ions was set to be constant and their directions set along the
external magnetic field, i.e., the z-direction (because of the short relaxation of electron spin, the
magnetic moment of a single spin was treated as in a thermal equilibrium state).

4.3.3 T1 measurement and experimental data fitting
T1 of NP samples was measured with an inversion recovery sequence on a 3 T Philips
imaging system, a 4.7 T Varian imaging system, a 7 T Varian NMR spectrometer, and an 11.7 T
Varian imaging system. For PFOB, the T1 was measured on the CF3 peak in its NMR spectrum
(36-38). According to Eq. 8, the undetermined constant C1 notwithstanding, four definite
parameters contribute to the relaxation enhancement ∆R1 : 1) diffusion coefficient D , 2) Larmor
frequency ωI , 3) particle size r , and 4) distance of closest approach d . The only parameter that
cannot be measured directly is the distance of closest approach d . Therefore, based on the NP
structural parameters and the measured relaxation enhancement, we opted to fit the experimental
data to Eq. 8 and test if it gave a reasonable estimate for d . The nonlinear fitting of the
experimental data to the theoretical prediction was executed in Mathematica (Wolfram Inc,
USA) based on the least squares principle.

4.3.4 In vitro demonstration of “19F relaxation switch” after cell internalization
αvβ3-integrin expressing RAW 267.7 murine macrophages (passage 4 or 5) were used for
all experiments to elicit active endocytosis of PFC NP. Incubations were carried out in gelatincoated T75 cell culture flasks with αvβ3-integrin targeted CE NP anchored with Gd-DTPA-BOA
(2 µl/ml). After being incubated for 2, 24 or 48 hour, cells were washed with PBS three times
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and then centrifuged to obtain pellets. 19F spectroscopic quantification was performed at an 11.7
T Varian small animal imaging scanner using previously reported methods (39). The 1H and 19F
longitudinal relaxation properties of the cells were measured on a 4.7 T Varian small animal
imaging scanner with an inversion recovery sequence. To confirm that other factors (e.g.
intracellular oxygen gradient) did not contribute to the change of 19F T1 after internalization, the
19

F T1 of internalized plain CE NP , i.e., without Gd chelates, was also measured.
For fluorescent microscopy of internalized PFC NP, another group of cells were

incubated with αvβ3-integrin targeted PFC NP colabeled with Alexa Fluor 594. Subsequently,
cells were fixed with 4% paraformaldehyde for 30 mins, mounted with DAPI media
[VECTASHIELD Inc., USA], and imaged with Olympus BX61 fluorescent microscope.

4.4 Results
4.4.1 Inhomogeneous magnetic field in NP

As shown in Figure 4.2, the magnetic field fluctuates considerably near the surface of NP
but is relatively homogeneous in the central part of NP. In addition, since the direction of
external field is the z-direction, the Gd-induced magnetic field is not isotropic and exhibits
slightly different distributions on the xy and xz-plane.
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Figure 4.2 Monte-Carlo simulation of Gd-induced magnetic field inside NP. X-component of the
field strength on the xy-plane and xz-plane of the NP are depicted in (a) and (b), respectively.
Inhomogeneous field distribution is visually appreciable close to the surface of the PFC NP.

4.4.2 Effect of the structural parameters on 19F ∆R1
Figure 4.3a illustrates the dependence of 19F ∆R1 on the radius of the NP according to Eq.
8. Because the paramagnetic ions are located only on the surface of the PFC NP instead of
mixing in the PFC core, the surface to volume ratio of the PFC NP results in the 1/ r
dependence of ∆R1 . This result agrees with the classical paramagnetic relaxation enhancement
phenomenon for an aqueous solution, in which ∆R1 is proportional to the volume concentration
of paramagnetic ions (14). Figure 4.3b plots ∆R1 as a function of the distance of closest approach

d . Selected combinations of diffusion coefficient D and external magnetic field B were
examined. In comparison to the 1/ d 6 dependence for pure inner-sphere relaxation scenarios, e.
g. immersion depth measurements (40) and protein structure determinations (41), it is evident in
Figure 4.3b that the decay of ∆R1 for paramagnetic NP relative to d is slower, in agreement with
previous results found by Polnaszek et al (18). Figure 4.3c depicts the relation between
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19

F ∆R1

and the external field strength B0 . Selected combinations of distance of closest approach d and
diffusion coefficient D are shown in different line styles. The longitudinal relaxation
enhancement of NP decreases monotonically when the external magnetic field increases over the
range of the field strengths plotted. Figure 4.3d illustrates the dependence of ∆R1 on the diffusion
coefficient D of the PFC molecule. The effect of D is complex and non-monotonic: the
maximal relaxation enhancement occurs for certain optimal combinations of d , D and Larmor
frequency ωI . The potential underlying mechanism for this non-monotonic behavior is
considered in detail in the Discussion.

Figure 4.3 Theoretical predication of relaxation enhancement as a function of particle
configuration. (a) Normalized relaxation enhancement ∆R1 as a function of particle radius. The
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value of ∆R1 is normalized to that when r =25 nm. ∆R1 is inversely proportional to the radius of
NP. (b) ∆R1 as a function of closest distant of approach. The radius of NP r is fixed to be 100
nm. The value of ∆R1 when D =50 µm2/s, d =0.5 nm and B =1.5 T is normalized to one. The

curve 1/ d 6 was plotted as the reference. (c) ∆R1 as a function of external magnetic field. r was
set to be 100 nm. The value of ∆R1 when D =50 µm2/s , d =0.5 nm and B =1.5 T is normalized
to one. (d) ∆R1 as a function of diffusion coefficient of PFC. The radius of NP r is fixed to be
100 nm. The value of ∆R1 is normalized to the maximum value in the graph.

4.4.3 Experimental validation
Diffusion coefficients of neat CE and PFOB measured at room temperature were 210
µm2/s and 200 µm2/s, respectively. The mean diameters of three types of paramagnetic NP were:
382 nm (polydispersity, 0.177) for PFOB NP with Gd-DOTA-PE, 270 nm (polydispersity,
0.082) for PFOB NP with Gd-DTPA-BOA, and 150 nm (polydispersity, 0.081) for CE NP with
Gd-DTPA-BOA. Figure 4.4a illustrates the longitudinal relaxation rates of CE NP, CE NP with
Gd-DTPA-BOA, PFOB NP, PFOB NP with Gd-DTPA-BOA, and PFOB NP with Gd-DOTA-PE
at different magnetic fields. For comparison with the theoretical prediction (see Figure 4.4b), we
used the relaxation enhancement of CE NP loaded with Gd-DTPA-BOA at 3 T as the reference
to eliminate the effect of the constant C1 . The ratio between ∆R1 of CE NP with DTPA-BOA-Gd
and that of all NP at various fields were fitted to Eq. 8. The fitting variable, the distance of
closest approach d, was the only parameter that varied among NPs due to the different chelate
linker lengths and penetration depths. The fitting results for the distances of closest approach are:
CE NP with Gd-DTPA-BOA, d = 0.9 nm; PFOB NP with Gd-DTPA-BOA, d =1.0 nm; and
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PFOB NP with Gd-DOTA-PE, d = 1.4 nm. Note that according to the chemical structure, the
length of all these linker chain is on the order of 1 nm, and that the Gd-DTPA-BOA has a shorter
linker than does Gd-DOTA-PE (34). Therefore, the experiment illustrates that the theoretic
prediction is qualitatively accurate. Additionally, the fitting result for d also provides a realistic
experimentally measured range for the distance between the diffusing 19F spins and the anchored
Gd ions.
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Figure 4.4 Theoretically predicted and experimentally measured relaxation of paramagnetic PFC
NP. (a) Experimentally measured R1 at various magnetic field strengths. (b) Relaxation
enhancement ∆R1 was extracted from the experimental data and compared with the theoretical
fitting. Fitting result gives reasonable estimate of closest distant of approach d for PFC NP with
DTPA-BOA-Gd and DOTA-PE-Gd.
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4.4.4 Biological application for tracking endosome function
Fluorescent microscopy confirmed the intracellular localization of Alexa Fluor 594 in
treated macrophages, suggesting internalization of PFC NP (Figure 4.5). Quantitative

19

F MR

spectroscopy (Figure 4.6a) showed that the number of PFC NP per macrophage increased
progressively within the first 48 hours following treatment with Gd-DTPA-BOA coated PFC NP.
The delivery of Gd chelates on PFC NP to macrophage cells was confirmed by the progressively
decreasing 1H T1 (or alternatively, increasing relaxation rate, 1/T1) (Figure 4.6b), reflecting the
local paramagnetic effect of Gd. However, after endocytosis, the

19

F T1 of PFC NP rapidly

recovered to the baseline value of plain PFC NP (i.e., without Gd coating) within 2 hours (Figure
4.6c). The

19

F T1 of internalized PFC NP remained at that level despite the continuous cellular

uptake of PFC NP. Based on the theoretical prediction of Eq. 8, the shortened 1H T1 but fully
recovered 19F T1 suggested that Gd chelates were rapidly separated from PFC NP upon endocytic
ingestion.

Figure 4.5 Fluorescent microscopy of PFC-NP treated macrophages with incubation time (a) 2
hours, (b) 24 hours, and (c) 48 hours. Blue=DAPI, red= Alexa Fluor 594, red scale bar = 10 µm.
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4.5 Discussion
Targeted paramagnetic PFC NPs represent a promising construct for quantitative
molecular imaging with magnetic resonance methods (4). In order to optimize such contrast
agents for use in biological environments that can present multiple variables that might influence
19

F relaxivity such as oxygen tension, pH, temperature, blood flow, and imaging field strength, it

is critical to understand 19F relaxation phenomena from first principles. This requirement is also
applicable to the relationship between relaxation properties and the physical composition of the
NP itself which can vary in size, shape, and lipid and PFC composition.
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Figure 4.6 Quantitative

19

F spectroscopy of internalized paramagnetic PFC NP. Number of

paramagnetic PFC NP per cells (a), proton longitudinal relaxation time (b), and fluorine
longitudinal relaxation time (c) after 2, 24, 48 hour incubation. Data represent mean ≤ SD (n=4).
In this work, we have developed a theoretical framework for understanding these
interactions and demonstrated the first order concordance between theory and measurement.
Several novel conclusions can be stated. Firstly, paramagnetic relaxation enhancement of

19

F

nuclei is observed in PFC NP because of the discrete distribution of Gd ions on the microscopic
scale that gives rise to an inhomogeneous magnetic field when closely opposed to the particle
surface. Secondly, the existence of a lipid monolayer barrier prevents the direct binding between
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Gd ions and PFC molecules resulting in a pure outer-sphere relaxation mechanism that is the
basis for the concordant predicted and observed relaxation behavior. Lastly, when Gd chelates
are stripped from the nanoparticle surface after cell internalization, a “19F relaxation switch”
occurs, revealing the transition from intact bound particle to processed constituents, which is
indicative of the intracellular endosomal material processing function.
According to SBM theory (29), paramagnetic relaxation enhancement of a PFC molecule

r
with nuclear spin I inside the NP is attributed to the time-dependent dipolar interactions
between the

19

F nuclear spin and the superposition of the magnetic fields produced by all

r
electron spins S from the Gd ions (21). Interestingly, considering classical electromagnetism, a

sphere with an ideally polarized magnetic shield should manifest a homogeneous internal
magnetic field distribution (42) wherein the dipolar interactions remains constant as PFC
molecules diffuse. However, because of the limited thickness of the lipid monolayer (around 1.5
nm), the distribution of Gd ions on the surface of PFC NP should be treated as discrete once the
point of interest is close enough to the surface (i.e., on the same order of the distance between
two neighboring Gd ions on the NP surface, which is around 1.4 nm for a NP with a diameter of
170 nm (16)).
It is notable that the distance of closest approach fitted from the experimental data is
smaller than 1.5 nm, which approximates the length of the hydrophobic tail of the lipid molecule
(16). The PFC molecules are known to penetrate the membrane lipid layer through diffusion and
act to reduce membrane tension, which explains their ability to come into sufficiently close
proximity to the Gd atoms on the NP surface to experience relaxation enhancement (37-38,43).
Despite departing from the traditional 1/ d 6 dependence (Figure 4.3b) for outer sphere
interactions, the paramagnetic relaxation enhancement effect still decreases dramatically with
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increasing d , demonstrating that a Gd coating situated close to the surface of the PFC NP
favorably enhances the relaxation of NP. These data are consistent with previous works from our
group that have shown that when a relatively larger d has been achieved by simply mixing of
the PFC NP emulsion and standard soluble Gd chelates that are not bound to the NP, the freely
diffusible Gd ions around the NP exert no effect on the relaxation property of PFC NP (16).
These results suggest that chelates with short linker chains would be preferred to form the
paramagnetic coating.
With respect to the outer-sphere relaxation mechanism, two time scales are involved in
the relaxation process for PFC nuclear spins: the time scale of diffusive motion d 2 / D , and the
period of the Larmor precession 1/ ωI (44). From the expression of ∆R1 (Eq. 8), a close match
between these two time scales is needed to achieve the optimal relaxation enhancement (Figure
4.3d). However, recognizing that it could be difficult to change the diffusion coefficient of the
PFC molecules (constant at a given temperature), an appropriate choice of external field strength
for imaging would be important to achieve the desired relaxation enhancement effect. Thus, a
relatively low magnetic field strength would be favored for 19F imaging with paramagnetic PFC
NP, not only because the longitude relaxation is greater under low field conditions, but also
because at high field the T2* of the PFC molecule tends to shorten significantly (16).
Together, these observations suggested an approach to tracking the function of
intracellular organelles such as endosomes, based on their expected roles as processors of
ingested materials.

Upon endocytosis of the PFC NP by professional scavengers such as

macrophage cells, the paramagnetic PFC NP structures are rapidly unpacked into PFC
components and separate Gd chelates. This result also explains similar previous experimental
observations in human umbilical vein derived endothelial cells (45). Because the 19F longitudinal
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relaxation is highly sensitive to the “distance of closest approach”, in the present study we only
observed two states for the paramagnetic PFC NP under the time constraints of the data
sampling: the fully intact form and fully unpacked form. However, in the future, it would be of
great interest to experimentally observe the dynamic change of

19

F T1 during the process of

endocytosis and then excretion, as a potential novel method for in vitro and even in vivo
assessment of NP uptake and cellular function.
There are several limitations to the proposed model and calculations that are worth
mentioning. First, the derivation was based on the theoretic treatment proposed by Solomon, in
which the zero field split energy has been neglected. Thus, our expression for ∆R1 does not hold
at low magnetic field when the spin orbit coupling is of the same order at the Zeeman energy.
Second, we have not considered the radial distribution of PFC molecule on the lipid monolayer
(46) and the electron relaxation time that might also affect the simulation result (44,47-48).
Third, although the internalization of Gd chelates was confirmed by intracellular 1H relaxation
enhancement using cultured cells, neutron activation would provide a more quantitative
measurement (16). Finally, the shielding effect of the chelate on the Gd electron spin has been
neglected by assuming the same magnetic moment of Gd ions for DOTA and DTPA.
Nevertheless, this theoretical framework might be expected to facilitate future chemical
modifications and applications of such agents with the goal of optimizing their sensitivity and
utility in clinical molecular imaging with unique, no background, and quantifiable readouts of
physiological and pathological biomarkers.
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5 Noninvasive blood oxygenation measurement using
19

F MRI

5.1 Introduction
Blood oxygen tension (pO2) is an essential pathophysiological index of circulatory and
respiratory health that is useful for characterizing various disorders such as congenital heart
disease (1), arteriovenous malformations (2), atherosclerotic dysfunction (3), and overt or occult
heart failure in general (4). The current gold standard for pO2 measurement entails direct blood
sampling using arterial puncture, or invasive catheterization when A-V O2 differences, or cardiac
output and oxygen consumption data are needed.
MRI has been exploited as an alternative tool for non-invasive assessment of blood
oxygenation based on blood-oxygenation-level-dependant (BOLD) MRI determined 1H R2* (5),
susceptibility (6), or T2 and T1 contrast (7-8). Among these methods, R2* and susceptibility
contrast generated by deoxygenated-hemoglobin (deoxy-Hb) can be used to estimate deoxy-Hb
concentration and blood saturation (SO2) because deoxy-Hb is highly paramagnetic.
Nevertheless, the readout of BOLD and susceptibility-dependent contrast is qualitative, or
otherwise requires organ-specific prior knowledge to build complex mathematical models (5-6).
Blood flow imaging with global T2 preparation has also been employed to measure blood
oxygenation because of its linear correlation with blood 1H R2. However, for in vivo studies, B1
and B0 inhomogeneity and pulsatile flow artifacts pose major obstacles for effective spin
preparation and consistent R2 estimation (8). Additionally, blood 1H R1 is also linearly
responsive to dissolved pO2 and thus may also be employed as a quantitative marker for blood
oxygenation. However, because of the limited solubility of O2 in plasma, the slope of 1H R1 as a
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function of pO2 is as low as 2×10-4s-1/mmHg, resulting in significant uncertainty for in vivo pO2
quantification (7).
Perfluorocarbon nanoparticles (PFC NPs) have been proposed as an 19F MR pO2 sensor
(9-10) as a consequence of two attributes: (a) O2 is a weakly paramagnetic molecule with
unpaired electrons and net magnetization; (b) O2 exhibits high solubility in PFC; (c) the linear O2
release response curve of PFC and the free O2 diffusion between PFC and surrounding
environment render PFC as a reliable pO2 probe for in vivo applications of measuring vascular
pO2 (11-12) and tissue oxygenation (9,13-14). Previous reports have demonstrated that the slope
of 19F R1 of PFC as a function of pO2 could be ten-fold greater than the dependence of 1H R1 on
pO2 (12-13,15). Additionally, because the lipid monolayer of PFC NPs is impermeable to
macromolecules and ions, free paramagnetic macromolecules and ions in the blood stream do not
affect the measurement of

19

F R1 emanating from PFC NPs, or its dependency on pO2 (16).

Finally, as a FDA-approved oxygen delivery vehicle, PFC NPs exhibit an acceptable bio-safety
profile for ultimate clinical use (17-18).
Similar to 1H MRI (19-22), one major obstacle of intravascular pO2 measurements based
on 19F T1 of PFC NPs is the blood pulsatile motion artifact and in-flow effect. Other limitations
include relatively low signal-to-noise ratio (SNR) due to limited amount of injected PFC NPs in
the blood pool, and the inhomogeneity of spin preparation due to the movement of arterial blood
through a large portion of body during the relaxation measurement. Therefore, the
implementation of novel 19F MRI strategies to minimize these artifacts would be critical to blood
pO2 measurements obtained by 19F MRI relaxometry.
In the present work, we have first demonstrated the feasibility of imaging blood
vasculature using

19

F MRI of circulating PFC NP. We have developed a novel Blood flow-
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Enhanced-Saturation-Recovery (BESR) sequence for measuring

19

F T1 of flowing PFC NPs in

blood pool. The BESR sequence preserves the time efficiency of the classical Look-Locker
sequence and the high SNR of saturation recovery sequence. We first performed a computer
simulation to illustrate the homogeneity of spin preparation in the BESR sequence, and to define
the effect of limited SNR on the precision of the pO2 measurement. The accuracy of BESR
sequence measured T1 was tested on a phantom and evaluated in vivo by measuring arterial 1H
T1 in carotid arteries and cardiac ventricles. Finally, we optimized scan times and PFC NPs
doses in conjunction with the BESR sequence for 19F imaging of circulating PFC NPs to provide
a quantitative estimate of arterial and venous pO2 in mouse heart ventricles under both normoxia
and hyperoxia conditions.

Figure 5.1 Illustration of the Blood flow-Enhanced-Saturation-Recovery (BESR) sequence. Spin
preparation is achieved with multiple non-selective saturation pulses; image acquisition uses a
gradient echo approach with cardiac triggering; saturation pre-pulse train and gradient echo
imaging are both triggered by ECG. Each image acquisition is acquired at the same trigger delay
time t but corresponds to different saturation delay time TS.
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5.2 Material and Methods
The BESR sequence was implemented and all images were acquired on a 4.7 T Varian
INNOVA scanner. All procedures in this study conformed to the guidelines and approvals by the
Animal Studies Committee of Washington University in St. Louis.
5.2.1 Blood vessel imaging using 19F MRI of circulating PFC NP
A healthy Swiss Webster mouse was anesthetized with ketamine/xylazine followed by
intravenous injection of 40% v/v perfluoro-15-crown-5-ether (CE) NP (5ml/kg). A

19

F gradient

echo imaging in the transverse plane of the neck region was performed to visualize the blood
vasculature in this region. Detailed imaging parameters were TR = 500 ms, flip angle = 90±, TE
= 2.5 ms, thickness = whole projection, in plane resolution = 0.3 mm µ 0.3 mm. Another Swiss
Webster mouse underwent unilateral carotid artery thrombotic injury induced by FeCl3. The
aforementioned 19F MRI and conventional 2D time-of-flight 1H angiography were performed to
evaluate the void of flow at the injured site.
5.2.2 Pulse sequence and imaging setup
The BESR pulse sequence is designed for measurement of pO2 in pulsatile blood flow. It
is composed of two parts: homogeneous spin preparation and time-of-flight image acquisition
(Figure 5.1). The spin preparation is achieved with a non-selective whole body saturation pulse
train and the image acquisition is realized with gradient echoes at high repetition rate. Both the
pre-pulses and imaging excitation pulses are gated to the ECG with appropriate trigger delay to
minimize the motion artifact associating with the beating heart and vascular contraction and
dilation.
In contrast to measuring the T1 of solid tissues, the spin preparation for measuring T1 of
flowing blood should be non-selective and homogenous over the entire subject because spins in
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the blood that will be excited for imaging might arise from a variety of locations during the spin
preparation step (22-23). To achieve homogeneous spin preparation, an actively-decoupled
transmit-only saddle coil (O.D. = 7cm, length = 12 cm) that covers the entire mouse body and a
composite RF saturation pulse train comprising five constitutive 90± sinc-shaped pulses are
employed. The bandwidth of each saturation pulse is 12 kHz and the time delay between two
adjacent saturation pulses is 2 ms, during which crusher gradients are applied along different
directions. The homogeneity of spin preparation is expected to improve progressively with the
number of 90± pulses in the saturation pulse train. Specifically, s ( x, y, z ) , the percentage residual
magnetization along z direction in a voxel positioned at ( x, y, z ) after n closely spaced saturation
pulses followed by crusher gradients can be written as

s( x, y, z ) = [cos(ϕ ( x, y, z ))]n ,

[1]

where ϕ ( x, y, z ) is the flip angle at ( x, y, z ) and is determined by the B1 field profile according
to ϕ ( x, y, z ) = B1 ( x, y, z )τγ , where γ is the Larmor frequency and τ is the pulse width. To
confirm the homogenous saturation over the region of interest (ROI), we first acquired a flip
angle mapping of our transmit coil on a water phantom (D = 6 cm, length = 10 cm) using a dual
angle B1 mapping approach with α = 30± (24). Quantitative residual magnetization mapping after
various number of saturation pulses (NSP) was then obtained by adjusting NSP in the BESR
sequence.
In traditional 1H saturation recovery T1 mapping, only one imaging excitation pulse is
allowed within a single TR to avoid partial saturation effects arising from frequent repetitive
excitations (25). In contrast, because of relatively fast blood flow in major blood vessels (>1
cm/s) and the “time-of-flight” effect, we anticipate that excited spins in the previous echo will
flow out of the imaging slice as long as the time interval between two temporally adjacent
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excitation pulses is sufficiently long (e.g., >0.2 s for 2 mm slice). Within a single TR of the
BESR sequence, multiple 90± excitations, each followed by a same phase encoding gradient, are
applied for gradient echo imaging. Thus, all echoes acquired in a single TR correspond to the
same k-space line at different saturation delays (TS). All the imaging excitation pulses are
synchronized with the ECG to minimize the effect of heart rate variations during imaging (26).
Finally, to achieve an optimal SNR with BESR sequence, a dedicated actively-decoupled
receive-only surface coil (diameter ≈ 3 cm) is placed close to the region of interest for signal
reception.
5.2.3 Estimating the effect of SNR on the accuracy of pO2 measurement
The uncertainty of the pO2 estimation caused by random noise in saturation recovery
imaging was evaluated using computer simulations in Matlab (Mathworks, USA) and
conventional saturation recovery imaging on PFC NPs phantoms. A region of interest (ROI)
containing 100 pixels was defined to simulate the number of pixels in heart ventricles. Normally
distributed Gaussian noise was imposed on the

19

F signal intensity in each pixel to achieve

variable SNR. The average noise-contaminated signal in entire ROI was used for non-linear
fitting of T1 values. The conversion between T1 and pO2 values was based on the pre-acquired
calibration curve. In the simulation, the following saturation delays were used: TS = 0.25, 0.5,
0.75, 1, 1.25, 1.5, 1.75, 2 and 10 s. Simulation was repeated 10000 times and the standard
deviation of the fitted pO2 was calculated to represent the measurement uncertainty propagated
from imaging noise through non-linear fitting. For phantom imaging, three PFC NPs phantoms
with volume concentration of 5%, 10% and 20% were sequentially bubbled with N2, room air
and O2 for 10 minutes. The phantom temperature was maintained at 37°C with a circulating
water bath. A saturation recovery fast spin echo sequence was used for T1 mapping: TR=3 s,
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FOV=25 cm × 25 cm, TE = 8.6 ms, echo train length = 16, Matrix size=128 × 128. The standard
deviation of the fitted pO2 values for each single pixel was used to calculate the uncertainty of
pO2 estimate in an ROI containing 100 pixels.
5.2.4 In vitro and in vivo validation of BESR sequence
The accuracy and precision of the BESR sequence was tested by measuring 1H T1 of
circulating water in a tube phantom, which simulated the in vivo setting of

19

F MRI with all

signal contributed only by intravascular PFC NPs devoid of tissue background. Briefly,
approximately 80 cm silicon tubing (1/8” inner diameter) was twisted and coiled to form an 8-cm
long phantom with multiple loops. The phantom was then connected to a pump to generate
constant 5 cm/s flow velocity to mimic blood flow. The special design of the phantom together
with the carefully chosen flow velocity simulate the blood flow situation in vivo, such that the
flowing water could experience a homogenous spin preparation at the beginning of each TR (5 s)
, but is moving rapidly enough to generate the desired “time-of-flight” effect to replenish the
imaging slice with unexcited spins before each gradient-echo (10 echoes in each TR ranging
from 0.1 s to 4.6 s time interval between consecutive imaging acquisitions = 0.5 s). Upon the
completion of BESR measurement, the pump was turned off and the 1H T1 of stationary water
was measured with a saturation recovery fast spin echo sequence. The image parameters of fast
spin echo were TR=5 s, TE = 8.6 ms, echo train length =16, TS=0.1 to 4.6 s with intervals of 0.5
s.
To confirm that the BESR sequence can achieve reproducible T1 measurements in vivo,
1

H T1 measurements of flowing arterial blood in carotid arteries and heart ventricles were

acquired in Swiss Webster mice (n=5) at 4.7 T. Mice were anesthetized through inhalation of
1.5% isoflurane ventilated by pure O2 (2 L/min). Body temperature was maintained at 37°C and
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ECG was monitored with a small animal monitor system (SAI Inc., USA). During MRI, the
isoflurane level was adjusted to maintain mouse heart rate at around 350 bpm. Imaging
parameters were: TR=2.5 s, TE = 2.8 ms, FOV=25 cm×25 cm, matrix size=96×96 and number of
TS=7. After in vivo imaging, mice were sacrificed and blood was collected from LV. T1 of the
collected stationary blood was measured using a custom-built solenoid coil and traditional
inversion recovery spectroscopy at 37°C after saturating with pure O2.
5.2.5 PFC NP formulation and in vitro T1 calibration
Perfluoro-15-crown-5-ether (CE) nanoparticles were formulated as previously described.
Briefly, the CE emulsion was composed of 40% (v/v) of CE (Exfluor Research Corp., USA),
2.0% (w/v) of a surfactant commixture, and 1.7% (w/v) glycerin, with water comprising the
balance. In vitro calibration of 19F R1 as a function of pO2 was performed at three different O2
concentrations (0%, 21%, and 100% O2 balanced with N2) by bubbling gas mixture into a CE
emulsion sample for 30–60 min at both room temperature and 37°C. 19F T1 measurements were
made using inversion recovery spectroscopy with TR=10 s, and 10 inversion delays (TI) ranging
from 3 ms to 5 s. To confirm that the linear response curve of CE NP on pO2 was preserved in
the blood, mouse blood (Bioreclamation, LLC, USA) containing 10% volume/volume ratio of
CE NP was placed in a gas chamber to allow gas exchange through semi-permeable silicon
tubing for 30 minutes. Blood was transferred to a sealed vial and the sample temperature was
maintained at 37°C. For the linear fitting, the conversion of partial percentage of oxygen to
mmHg was based on the assumption that 100% oxygen is equivalent to 713 mmHg (considering
the vapor pressure at 37°C is 47 mmHg).
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5.2.6 Noninvasive intravascular pO2 measurement with BESR 19F imaging
Swiss Webster mice (n=5) were anesthetized with 1-2% isoflurane mixed with room air
or O2 followed by intravenous injection of CE NP (5 ml/kg) via the tail vein. The 19F signal from
isoflurane was barely detectable by MRI in contrast to the strong 19F single emanating from CE
NP in the blood stream, which is likely due to low blood/tissue retention and the short T2* of
isoflurane (27).1H gradient-echo cine images were acquired initially to position the slices to
cover both left and right ventricles (LV and RV). Blood 19F T1 measurements were carried out
under separate conditions of room air and then pure oxygen ventilation. The saddle coil and the
surface coil were re-tuned as needed to the proper frequency of 201.5 MHz and 189.6 MHz for
1

H and

19

F imaging, respectively. Parameters for

19

F BESR T1 measurement were: TR, 2.5 s;

TE, 2.2 ms; number of points along recovery curve, 8; number of averages, 16; in plane
resolution, 1.5 mm × 0.75 mm; slice thickness, 2 mm. In order to optimize non-linear fitting for
19

F T1 of less-oxygenated venous blood exhibiting T1 > 2 s, another set of BESR images

acquired with identical imaging parameters but without pre-saturation pulses were used as fully
recovered signal. The previously measured

19

F R1 vs pO2 calibration curve was used for

quantifying intravascular pO2 in vivo.
5.2.7 Data analysis and statistics
The left and right ventricles and vessel lumen were manually segmented on 1H and

19

F

images. ROI was defined as the region exhibiting > 3 SD higher 19F signal intensity, i.e., signal
contributed by PFC NPs in the blood, as compared with that of surrounding tissues. The average
intensity in each ROI was used for fitting data to a 3-parameter saturation recovery curve:

S (TS ) = A − Be−TS /T1 .

[2]
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All statistical analysis was performed using Origin software (OriginLab, USA). Metrics
for precision and accuracy of T1 measurements with the BESR sequence were assessed based on
1

H image of the tubing phantom. The precision error was calculated as the root-mean-square of 5

individual measurement normalized by the mean value, and the accuracy error was considered to
be the relative difference between the T1 mean value measured using a reference method and the
BESR sequence. A two sample paired t-test was used for statistical analysis to test the difference
between BESR measured 1H T1 values and reference 1H T1 values in vivo, and the difference of
19

F MRI determined pO2 between hyperoxic and normoxic conditions. A significance threshold

of p < 0.05 was used for hypothesis testing.

Figure 5.2 Saturation profile of saturation pulse train of BESR sequence. (a, b) Flip angle
mapping of a water phantom in axial and coronal plane. (c, d) Measured residual magnetization
after different number of saturation pulses (NSP = 1, 3, 5) in axial and coronal plane. The yellow
dashed lines represent the border of the ROI for in vivo study. The residual magnetization inside
the ROI is presented as mean ≤ standard deviation.
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5.3 Results
5.3.1 Measurement of the homogeneity of pulse train saturation
The flip angle mapping of the transmit coil and the percentage residual magnetization
intensity after different number of saturation pulses (1, 3, and 5) were measured experimentally
and shown in Figure 5.2. As the number of saturation pulses increased, spin nulling in the whole
FOV became more uniform despite the inhomogenity of the B1 profile. After five consecutive
90± pulses, the residual magnetization within the ROI where mice were placed for in vivo
experiments (border marked by yellow dash line) was < 4%, substantially lower than the > 20%
residual magnetization after a single saturation pulse.
5.3.2 19F MRI of PFC NP in the blood pool
PFC NP in blood vessels at the neck region was readily visualized using 19F MRI (Figure
5.3). The angiograms generated from whole projection of

19

F MRI and maximal intensity

projection (MIP) of 1H angiography automatically co-registered with each other. Void of blood
flow in the left carotid artery caused by the external injury was detected by both

19

F and 1H

angiography. It is notable that compared to 1H MIP, 19F angiography features a non-background
delineation of blood vasculature.
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Figure 5.3
19

19

F angiography in mouse. (a) shows a “maximal intensity projection” of the 1H and

F angiograms at the neck of mouse, where blood vessel geometry is clearly depicted. The

thrombus site in the carotid artery is visually appreciable in

19

F angiography (b), which is

consistent with the time-of-flight 1H imaging (c).
5.3.3 Validation of BESR sequence determined T1
The 1H T1 measured in the tube phantom and in arterial blood flow is summarized as
follows: BESR sequence determined 1H T1 of circulating water (2.96 ≤ 0.43 s) was comparable
to that of stationary water measured with a traditional saturation recovery sequence (3.30 ≤ 0.17
s, N.S.). The precision and accuracy errors were 13.0% and 10.3%, respectively. The precision
and accuracy errors provide quantitative estimates for the potential measurement bias and
uncertainty, respectively. The in vivo measured 1H T1 in arterial blood (on 100% O2) in left and
right carotid arteries and left ventricle were 1.62 ± 0.12 s, 1.59 ± 0.2 s, and 1.67 ± 0.14 s,
respectively. The corresponding in vitro T1 of sampled arterial blood saturated with 100% O2
was 1.78 ± 0.18 s (N.S. compared to all in vivo measurements).
5.3.4 In vitro calibration of 19F R1 as a function of pO2
In vitro measurements validated the linear dependence of 19F R1 on pO2 (Figure 5.4). At
37±C,
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R1( s −1 ) = (0.396 ± 0.014) + (0.0024 ± 0.0003) × pO2 (mmHg ) .

[3]

Deoxy-Hb did not exhibit any observable paramagnetic relaxation enhancement effect on 19F T1,
because 19F R1 vs pO2 curve was identical in aqueous solution and mouse blood.

Figure 5.4 Calibrated linear relationship between

19

F R1 and pO2 at room temperature and 37±.

The calibration curve at 37± is used for the in vivo study. Error bars represent standard deviation.
5.3.5 In vivo measurement of blood oxygenation
Figure 5.5 shows representative BESR images of a mouse heart under hyperoxia and
normoxia. After spin saturation, blood in the left ventricle (LV) exhibited a faster recovery of
signal intensity than that in the right ventricle (RV), which was further accelerated when the
mouse was breathing pure O2 (i.e., hyperoxia). The fitted 19F R1 confirmed the faster relaxation
of the more oxygenated blood. Based on the calibrated correlation between 19F R1 and pO2 (Eq.
3), 19F MRI-measured LV blood pO2 was 458 ≤ 133 mmHg under hyperoxia and 96 ≤ 21 mmHg
under normoxia; significantly higher than RV blood pO2, which was 103 ≤ 21 mmHg under
hyperoxia and 49 ≤ 15 mmHg under normoxia (Figure 5.6, p < 0.05 for all comparisons).
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Figure 5.5 In vivo

19

F BESR MRI of heart ventricles. (a) A short-axis 1H image shows the left

and right ventricles. (b)
normoxia. (c-d) Fitted

19

F BESR images of the same mouse heart under hyperoxia and

19

F saturation recovery curve for LV and RV blood under normoxia and

hyperoxia. Error bars represent standard deviation.
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Figure 5.6 Ventricular pO2 estimated using BESR sequence. Measured blood pO2 based on
measured

19

F T1 of PFC NPs showed pO2 difference between LV and RV, and between

normoxic and hyperoxic conditions for each ventricle, *, p<0.05.
5.3.6 Accuracy of pO2 measurements at different SNR
Since low SNR is a common problem in

19

F MRI, the effect of SNR on

determined pO2 was evaluated by mathematical simulation (Figure 5.7).

19

F BESR

As expected, the

accuracy of 19F MRI measurements of pO2 increased with SNR. However, the pO2 measurement
was less susceptible to noise (in the sense of absolute measurement uncertainty) at lower oxygen
tension. When image SNR = 9, the measurement error of

19

F MRI determined pO2 was <10

mmHg under hypoxic condition (pO2 <50 mmHg) and <40 mmHg under hyperoxic condition
(pO2 > 500 mmHg). Phantom studies with varying concentrations of PFC NPs (Figure 5.7b)
confirmed the simulation result. Higher imaging SNR substantially reduced the uncertainty and
increased the precision of the 19F R1 measurements.
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Figure 5.7 Effect of SNR on the accuracy of pO2 measurement. (a) Simulation result shows
measurement accuracy improves as SNR increases. pO2 measurement uncertainty is higher under
hyperoxic condition. (b) Measured pO2 for three PFC NPs samples with different NP
concentration bubbled with N2, Air and O2, respectively. The mean value of measured pO2 is
independent of PFC NPs concentration but measurement uncertainty (error bars) is suppressed
by increased SNR.

5.4 Discussion
In the present work, we experimentally demonstrated the feasibility of 19F angiography in
mouse. We have implemented a novel BESR sequence to quantify blood pO2 based on 19F R1 of
circulating PFC NPs. Because 19F R1 of PFC NPs is not affected by the paramagnetic effect of
deoxy-Hb and manifests a linear association/release curve as a function of dissolved [O2], it
represents a promising probe to quantify blood pO2. Our results demonstrate that the BESR
sequence: 1) achieves a consistent T1 measurement for pulsatile blood flow, 2) differentiates
blood pO2 in the LV and RV, and 3) depicts the response of ventricular blood oxygenation to
hyperoxic challenge.
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One concern regarding the use of any oxygen sensing probe in vivo is whether other
molecules or ions will affect the chemical properties of the probe. In this study, we observed that
pO2 -

19

F R1 relationship remained unchanged for PFC NPs in salt solution and blood sample.

This is consistent with our previous findings that

19

F R1 of PFC NPs is not affected by

surrounding free paramagnetic ions (16,28) since their direct interactions are prevented by the
lipid monolayer of PFC NPs, which is permeable to O2 but not to macromolecules. The observed
linear pO2 response curve of PFC NP agreed with that observed in previous reports despite the
difference in the fitted coefficient at different magnet field strength (12,29-30).The observed
temperature dependence of 19F R1 has also been previously reported (15).
The long circulating half life time of PFC NPs and high 19F spin density are advantageous
to use PFC NPs as a blood pool pO2 probe. The mean half life of PFC NPs in the blood plasma is
~180 minutes in mouse and even longer in humans (31). Thus, the slow clearance of
intravascular PFC NPs allows a relatively wide temporal window for quantitative pO2
assessment with

19

F MRI. In addition, even though PFC has high affinity for O2, the modest

administered dose is small enough such that the total amount of dissolved O2 carried by PFC NPs
is orders of magnitude less than that carried by plasma and red blood cells (dissolved plus oxyhemoglobin) (32-34). Therefore, the blood-pool PFC NPs acted as a pO2 sensor rather than a
primary O2 reservoir and the 19F MRI measured pO2 values reflects pO2 in blood stream.

In major arteries (or ventricles), and veins, the velocity of blood flow is > 10 cm/s and 1
cm/s, respectively. For a typical imaging slice thickness (1-2 mm), the minimal time required for
blood to flow through the slice is approximately 100-200 ms. By setting the time interval
between two consecutive excitation pulses greater than 200 ms and selecting imaging slices
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perpendicular to the flow direction, the previously excited spins should not affect the subsequent
image acquisitions. Thus, gradient echo imaging with 90± excitation pulses can achieve maximal
SNR without partial saturation effects. On the other hand, because the blood flow is rapid in
major blood vessels, during the recovery process of the T1 measurement the real “imaged” spins
within the region of interest may originate from distant locations. This requires homogeneous
spin pre-saturation over a large volume of the imaged subject. Consistent with previous studies
that utilized pre-saturation pulse trains (33,35), our result suggests that a non-selective saturation
pulse train with crusher gradients was robust for reducing both B0 and B1 inhomogeneity while
achieving a satisfactory uniform spin saturation profile. By implementing multiple saturation
recovery acquisitions in each TR, the BESR sequence achieved higher SNR than traditional
saturation recovery or inversion recovery T1 measurement sequences.
The novelty of BESR resides in the utilization of a homogenous RF pre-saturation and a
train of ECG gated excitation/readouts in a single TR for fast T1 quantification. Due to the
refreshing of intravascular PFC NP in the imaging slice ( thickness = 2 mm) between adjacent
heart beats, the acquired blood-pool

19

F signal by each readout directly represents the

19

F T1

recovery at corresponding delay times after saturation. In contrast, the conventional saturation
pulse sequence only acquires one echo after each RF saturation, and the different T1 recovery
weighting is achieved by varying TR (36). Thus, the BESR sequence provides a faster imaging
method for quantifying blood

19

F T1 by taking advantage of the time-of-flight effect of blood-

flow in conjunction with intravascular PFC NP contrast agent. Although multiple 90± pulses
were used in this study, other pulse shapes such as adiabatic or composite pulses also could be
employed as long as homogeneous whole-body saturation is achieved (37). Similarly, fast

109

imaging techniques like EPI could replace the single echo to further accelerate image acquisition
(36).
The BESR sequence is optimized for
intravascular agent; (b) there is no

19

19

F MRI because: (a) the PFC NP is an

F background in soft-tissue; (c) O2 dissolving and release

from PFC NP (~250 nm) operates through free diffusion that occurs in milliseconds (38). In
capillaries, the measured pO2 may directly reflect tissue pO2 if the O2 exchange between tissue
and microvasculature is rapid (39). In ventricles and major blood vessel that experiencing no
blood-tissue O2 exchange, the measured pO2 would represent venous or arterial blood pO2.
Finally, although the BESR sequence could be applied to quantify 1H T1 in blood pool, the small
correlation coefficient between

1

H R1 and pO2 may be problematic for accurate pO2

determination. Additionally, the O2 release response curve of hemoglobin is non-linear, therefore
the accuracy of 1H MRI measured blood pO2, as well as its relationship with tissue pO2, remains
to be defined.
The proposed

19

F imaging methodology has direct translational potential. The technique

might be readily adapted to evaluate arteriovenous pO2 difference for selected organs, e.g. renal
arteries and veins for kidney, carotid arteries and jugular veins for brain, aorta and coronary
sinus for heart, among others. Further integration of
contrast 1H or

19

19

F MRI determined A-V pO2 with phase-

F MRI determined blood flow velocity may enable assessment of oxygen

consumption in individual organs as a critical pathological marker for evaluating injury at a
cellular level.
Based on the accuracy profile of 19F-determined pO2, imaging noise significantly affects
the measurement uncertainty of pO2 through non-linear T1 fitting. Therefore, the acquisition of
19

F images with sufficient SNR is crucial to accurately estimate intravascular pO2, which also
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was reported previously by Barker et al (14). In the present study, all images exhibited SNR > 7,
and according to our simulation (Figure 5.6a), pO2 estimates from these images could achieve a
measurement uncertainty as low as 10 mmHg under normoxia and 30 mmHg under hyperoxia
depending on real pO2.
Several limitations of the current pO2 measurement paradigm should be mentioned. Even
though the blood flow in major blood vessels is fast enough to create “time-of-flight”
phenomenon, the velocity profile of blood flow is laminar, where the velocity close to the blood
vessels walls is virtually zero. This portion of the blood may contribute to 19F signal resulting in
reduced accuracy of pO2 measurement in such regions (22). In the cardiac ventricles and major
vessels, non laminar blood flow (e.g., turbulence) also may cause errors in T1 estimation due to
spin de-correlation, which is not unexpected and can be visualized on 1H images for proper data
interpretation (40). Because the ejection fraction of normal ventricle is around 60%, after two
heart beats around 16% residual blood still remains in the same ventricle. The residual blood
may suffer from partial saturation from previous excitation and cause errors in T1 measurement.
The systematic error (about 6% of T1 measured in phantom experiments) caused by these factors
may be corrected by flow dynamical modeling in the future. The relative error of 19F BESR MRI
determined blood pO2, (i.e., 50 mmHg) in well oxygenated arterial blood or in venous blood (10
mmHg), could limit the application of this technique for measurement of tumor oxygenation, but
there are other uses that offer insights into myriad pathophysiologies. Finally, for human
imaging, where sampling once per cardiac cycle is too slow because of lower heart rate, the
sequence should be modified to image more than once per cardiac cycle.
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6 Functional 19F renal MRI
6.1 Introduction
In healthy kidneys, the countercurrent design of blood vessels and tubules maintains the
necessary osmolar gradient to permit efficient urinary concentration, yet the system operates
under conditions of a relatively hypoxic environment in some regions requiring extensive
extraction of oxygen from flowing blood (1-4). During acute and chronic kidney injury, ischemia
further hampers effective O2 delivery to the capillary bed of renal tubules, as extraction of extra
oxygen is marginal, resulting in exquisite susceptibility to ischemic damage to the renal medulla
culminating in renal failure, hypertension from chronic kidney disease, and even death (5).
Because acute kidney injury (AKI) is increasing in the hospitalized patient population, the
development of quantitative and repeatable measurements of renal circulatory function (e.g.
blood volume, perfusion, and regional oxygen tension) could enhance pathophysiological staging
of the early disease process and its response to therapy (6). To this end, we sought to design and
implement multiparametric quantifiable noninvasive imaging approaches that avoid the use of
nephrotoxic contrast agents.
The current standard approaches for imaging renal perfusion entails bolus injection of
exogenous contrast agents (e.g. iodinated compounds for CT, gadolinium chelates for MRI, etc.)
following by a series of image acquisitions (e.g. X-ray, SPECT, PET, MRI) to capture the firstpass dynamics of contrast agents flowing through the kidney (7-9). Despite the general
acceptance of these methods, heightened concern persists regarding their application in patients
with potentially compromised kidney function (10). Indeed, the potential for contrast-induced
nephropathy that can dramatically accelerate renal damage calls for great caution or even
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avoidance of their use in the patients with acute and/or chronic kidney disease (11-14). Even
with the use of gadolinium agents formerly thought to be devoid of such toxic side effects, slow
and incomplete clearance can enhance susceptibility to untreatable conditions such as
nephrogenic systemic fibrosis (15-16). Over the past two decades, the development of
noncontrast MRI techniques has lead to promising new image-based measures of kidney function
(17-19). Among these, Blood-Oxygenation-Level-Dependent (BOLD) MRI has demonstrated
potential for correlating intrarenal oxygenation with 1H susceptibility (T2*) measures (20).
Arterial Spin Labeling (ASL) MRI also has been touted as a clinically available technique for
defining renal perfusion without the need for exogenous contrast media (21). However, the lack
of widespread adoption of available BOLD and ASL MRI methods raises questions as to their
ultimate clinical utility (22-24).
Alternatively, Perfluorocarbon (PFC) based Nanoparticles (NPs) are a class of clinically
approved vehicles recently applied in vivo for targeted molecular imaging and non-invasive
oxygen tension (pO2) assessment (25-26). As compared with iodinated or Gd contrast agent, PFC
NPs may be especially suited to patients with kidney disease. As approved blood substitutes,
PFC NPs are biologically inert and exhibit a good safety profile with no renal toxicity reported in
both animals or human (27). Because PFC NPs (nominal size = 250 nm) are not cleared through
glomerular filtration (28), they do not increase kidney workload, which is a major risk factor for
kidney failure with other agents that undergo renal clearance (14). For imaging purposes, the
unique 19F MR signal emanating from the fluorine core of PFC NPs can be measured directly in
vivo in rather sparse concentrations (picomolar) with no background signal as might be the case

for other paramagnetic or superparamagnetic moieties that exert indirect contrast effects on
circulating protons (29-30). PFC NPs have been demonstrated as effective functional probes for
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both blood volume and pO2 determination. Specifically, the detected 19F signal intensity directly
reflects the actual quantity of PFC NPs within a voxel. Furthermore, the

19

F longitudinal

relaxation rate (R1) responds directly to local oxygen content in a linear manner (31-32).
Inflammation-coagulation interaction induced capillary non-perfusion is a primary
pathology of AKI (33). Inflammation activates coagulation through three major pathways:
thrombin generation mediated by tissue factor; fibrin deposition after fibrinolysis inhibition; and
down-regulation of the protein C. The pro-coagulant effect could be further enhanced by the
activated platelets (34-36). PPACK is a potent anti-coagulation agent that inhibits thrombin
activation and interrupts fibrin formation (36). The binding of PPACK-thrombin complex to
platelets inhibits their activation. We have recently demonstrated that PPACK loaded PFC NPs
could function as an in vivo anti- coagulation agent that effectively delays arterial thrombosis in
mice (37).
The objective of this study is to develop a 19F MRI contrast paradigm for functional renal
imaging. Here we demonstrate in healthy kidneys the feasibility of using

19

F MRI to directly

register renal blood volume (RBV) and intrarenal oxygen tension pO2. As compared with BOLD
and ASL MRI, the19F MRI method requires no model-based assumptions for absolute
quantification of renal physiological indexes. To evaluate the diagnostic capability of kidney 19F
MRI, we tested the approach in an established mouse model of ischemia-reperfusion AKI (38).
Based on the results, we propose that the functional readouts generated by

19

F MRI in concert

with PFC NP, alone or perhaps combined with traditional BOLD MRI, could facilitate
comprehensive quantitative assessment of micro-circulatory status in AKI.
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6.2 Material and Methods
All procedures, including treatment, MRI imaging and animal surgery, in this study
conformed to the guidelines of and with the approval of the Animal Studies Committee of
Washington University in St. Louis.
6.2.1 Nanoparticle formulation and calibration of 19F R1 vs pO2
Perfluoro-15-crown-5-ether (CE) nanoparticles (NPs) were formulated as previously
described (30). Briefly, the CE emulsion was composed of 40% (v/v) of CE (Exfluor Research
Corp., USA), 2.0% (w/v) of a surfactant commixture, and 1.7% (w/v) glycerin, with water
comprising the balance. CE NP was also co-labeled with Alexa Fluor 594 to enable ex vivo
fluorescence microscopy examination. In vitro calibration of

19

F R1 as a function of pO2 was

performed at three different O2 concentrations (0%, 21%, and 100% O2 balanced with N2) by
bubbling gas mixtures into a CE emulsion sample for 30 minutes at 37°C. 19F T1 measurements
were made with inversion recovery spectroscopy at TR=10 s, with 10 inversion delays (TI)
ranging from 3 ms to 5 s.
6.2.2 In vivo 19F and BOLD MRI of kidney
Mice were anesthetized with a continuous intramuscular infusion of ketamine/xylazine.
Body temperature was monitored and maintained at 37 ≤ 1°C during the MRI scans with the use
of a small animal monitoring system (SAI Inc., USA) and a feedback controlled heated fan
system. Mice were restrained in a custom-built holder and allowed to breathe pure oxygen
through a nose cone. The respiratory signal was acquired from additional tubing connected to the
nose cone and used as the gating trigger for in vivo imaging.
All in vivo imaging was performed on an 11.7 T Varian scanner with a custom-built
actively decoupled coil pair. The transmit coil (5 cm by 10 cm) was built to cover the entire
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imaging field of view, and optimized for superior field homogeneity and power transmit
efficiency. Mice were imaged in a supine position and the surface receive coil (1 cm by 2 cm)
was adjusted to match the mouse body curvature. Because of the strong magnetization
originating from the high field strength, the 1H signal was sufficient to generate high quality
anatomical image within a minimal scan time (< 5 minutes) despite being slightly off-resonance.
Thus, both transmit and receive coils were tuned and matched at 19F frequency for both 19F and
1

H imaging.
Before in vivo MRI, 0.1 mL (~ 5mL/Kg) CE NP was administrated intravenously through

the tail vein. A 1H gradient echo sequence was employed to locate the region of interest (ROI)
followed by a 1H multi-echo gradient echo BOLD scan with: TR = 100 ms, TE = 1.96 ms with
1.75 ms increment for every echo, flip angle = 10°, field of view = 26 mm × 26 mm, voxel size =
0.2 mm × 0.2 mm × 2 mm. Two sets of 19F MRI scans (spin density weighted and T1-weighted
images) were performed using a respiration-gated fast spin echo sequence. TR was set to 4 s for
the spin density weighted 19F MRI whereas the TR was set to two respiration periods for the T1weighted imaging. All other imaging parameters are identical in these two sets of 19F MRI: ETL
= 4, TE = 11.5 ms, receive bandwidth =20 kHz, voxel size = 0.4 mm × 0.4 mm × 2 mm, and the
field of view identical for 1H scout and BOLD imaging.
6.2.3 Quantification of renal blood volume and intrarenal pO2 (n = 5)
In order to quantify intrarenal blood volume and oxygenation, an external standard with
known concentration of CE NP was placed at the edge of animal holder for all in vivo

19

F

imaging. The CE NP reference comprised [ NPstd ] =5 ml/L CE in agarose gel to avoid NP
aggregation. We performed spatial sensitivity mapping of the RF coils on a saline phantom
placed into the mouse holder and positioned at the intended imaging location. The imaging
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parameters were: TR = 100 ms, TE = 1.96 ms, and flip angle = 10°. The phantom image
provided a pre-determined correction factor R ( x , y , z ) , which was the inverse of the absolute
signal, to normalize all in vivo measured 19F signal intensities, which compensated for the effect
of sensitivity profile inhomogeneity on received signal (39).
Immediately after in vivo

19

F imaging, blood was drawn from the left ventricle and the

blood sample was placed beside the external standard for ex vivo

19

F imaging using a custom-

built 19F solenoid coil. The average signal intensity ratio between the blood sample and external
standard offered a direct measurement of the CE NP concentration in the circulating blood

[ NPblood ] (ml/L). The detailed scan parameters for ex vivo imaging were identical to the spin
density weighted 19F MRI in vivo.
By combining ex vivo calibration and in vivo

19

F MRI, we calculated the renal blood

volume (% of voxel volume or tissue weight) in each imaging voxel based on the following
equation:
RBV ( x, y , z ) =

Slong ( x, y , z ) × R ( x, y, z ) × [ NPstd ]
S long ( x0 , y0 , z0 ) × R ( x0 , y0 , z0 ) × [ NPblood ]

,

[1]

where Slong ( x, y , z ) and Slong ( x0 , y0 , z0 ) are the signal intensities at the kidney and the external
standard in the

19

F spin density weighted images. R ( x , y , z ) and R( x0 , y0 , z0 ) are the correction

factors at the location of kidney and the external standard.
In vivo renal T1 quantification and pO2 measurement were based on the fundamental

assumption that image signal intensity in a fast spin echo sequence depends on TR and follows a
saturation-recovery process:
S (TR ) = S0 (1 − e −TR /T 1 ) ,

[2]

122

where S0 is a TR-independent baseline parameter. Such a formalism is accurate to the first order
when TE << TR in a fast spin echo sequence (40). In the present study, TR for spin density and
T1-weighted images were 4 s and ~1 s respectively (or ~400 and ~100 times longer than TE =
11.5 ms, respectively). Therefore, Eq. [2] was applicable for approximating the signal intensity
in renal 19F images.
Because T1-weighed

19

F MRI was gated with respiration, the real TR might vary from

animal to animal. Therefore, the real TR was determined retrospectively from the ratio of the
signal intensities of the external standard in the spin density weighted 19F MRI and T1-weighted
19

F MRI in vivo:

TRshort = −T 1s t d × ln(
where T1s t d is the

Sshort ( x0 , y0 , z0 )
),
Slong ( x0 , y0 , z0 )
19

[3]

F T1 in the external standard that is directly measured in vitro,

Sshort ( x0 , y0 , z0 ) and Slong ( x0 , y0 , z0 ) are the signal intensities of the external standard in T1weighted and spin-density weighted 19F MRI. Here we also accounted for the fact that in the spin
density weighted image, TR > 4 s could be assumed to be sufficiently long that there was no T1
effect in this image because it was over 3 times longer than the normal 19F T1 in kidneys. With
real TR acquired from external standard, voxel-wise T1 mapping of the kidney could be
calculated as

T1( x, y, z ) =

TRshort
.
ln( Slong ( x, y, z )) − ln(Sshort ( x, y, z ))

[4]

Finally, T1 values were translated into corresponding pO2 levels according to the pre-determined
calibration curve relating 19F relaxation and oxygen tension.
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6.2.4 Mouse acute kidney injury (AKI) model
C57/Bl mice (n=10) underwent laparotomy and a standard procedure to produce warm
ischemia-reperfusion injury (41). Briefly, mice were anesthetized with ketamine/xylazine
followed by a mid-line incision on the abdomen. After exposing the vasculature of the left
kidney, we induced ischemia by ligating both renal artery and vein with a suture. Cessation of
renal blood flow and restoration of perfusion after releasing the ligatures were confirmed
visually by noting the color change of the kidneys. Mice with incomplete ischemia or reperfusion
were excluded prospectively from the study. Ischemia was maintained for 60 minutes, during
which mice were kept warm with a water-circulating blanket at 37±C. To avoid dehydration of
exposed organs, warm saline was added to the abdominal cavity during ligation. 24 hours after
surgery, both injured and contralateral kidneys were scanned with functional 19F and BOLD MRI
in vivo as described previously. After in vivo MRI, 10 µl FITC-lectin (Vector Laboratory, USA)

was injected into the left ventricle and allowed to circulate for 5 minutes. Both kidneys were
harvested and frozen in OCT media (Tissue-Trek, Japan) for fluorescence microscopic imaging
and histological preparation.
6.2.5 Histology and fluorescence imaging
Frozen tissues were sectioned into 8 µm slices for histology and fluorescence imaging.
Briefly, hematoxylin and eosin were used to stain kidneys to confirm tissue damage caused by
ischemia-reperfusion. Fluorescence images were digitized with an Olympus BX61 fluorescent
microscope after mounting with DAPI mount media (Vectashield Inc., USA). DAPI, Texas Red
and FITC channels were selected to image the nucleus, CE NP, and perfused blood vessels
respectively. All fluorescence images were color coded and co-registrated in IMAGEJ (NIH,
USA).
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6.2.6 Treatment evaluation for PPACK NPs in AKI
PPACK NPs was prepared using our previously described protocol to achieve an average
loading of 13,650 PPACK on each particle. Animals were injected with PPACK NPs (N = 3) or
plain NPs (N =3) at 15 minutes before experiencing 45 minutes ischemia (dose: 1 mL/Kg). At 3hour after reperfusion, animals were euthanized and perfused with saline to washout blood-pool
NPs in perfused vessel. Ev vivo spectroscopic quantification of retained NP concentration was
performed using a standard single pulse

19

F spectroscopy sequence and a sample of 10 µl

trifluoroacetic acid (TFA, 0.1% volume concentration) as external reference standard. Ex vivo
19

F spin density weighted imaging was also performed for all kidneys using the identical protocol

as in vivo 19F imaging as described earlier.
6.2.7 Data processing and statistics
All MRI images and signal analyses were processed with a custom-designed program
written in Matlab (MathWorks, USA). Segmentation for different regions in healthy kidneys was
performed manually based on

19

F spin density weighted and 1H T2* weighted images. All

statistical analyses were conducted in Origin (OriginLab, USA): paired t-tests and repeated
measures ANOVA were used for hypothesis testing as indicated.
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6.3 Results
6.3.1 1H and 19F MRI of healthy kidneys

Figure 6.1 In vivo 1H and 19F images of healthy kidneys. (a & b) Representative T1-weighted and
T2*-weighted 1H MRI of mouse kidneys in the transverse plane. (c & d) Representative spin
density weighted and T1-weighted

19

F MRI of mouse kidneys in the transverse plane. Slice

planning is identical for 1H and 19F images and kidneys were zoomed in for better visualization.
(C: cortex, CM: cortico-medullary junction, M: medulla, REF: external reference standard).
Representative 1H T1-weighted, 1H T2*-weighted, 19F spin density weighted, and 19F T1weighted images are shown in Figure 6.1. Contrast between the renal cortex and medulla could
be visualized in all images. The high rate of oxygen consumption under physiological conditions
further reduced the signal intensity at the region of the cortico-medullary junction in 1H T2*weighted images. It is notable that the 1H T2*-weighted image (i.e., BOLD) could not accurately
depict the relative oxygenation at the renal medulla because most of the blood volume in this
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region is contributed by large blood vessels, which do not create a detectable field
inhomogeneity at the microscopic level, a necessary condition for BOLD signal imaging (42-43).
19

F spin density weighted images directly represented the relative perfusion within different

regions of the kidneys. Specifically, 19F signal intensity decreased from the cortex to the corticomedullary junction and increased again at the medulla. In the inner portion of kidney where both
medullary microvasculature and major renal artery/vein are present, relatively higher

19

F signal

was detected that correlated directly with local blood concentration. Finally, in 19F T1-weighted
images,

19

F signal intensity throughout the entire kidney was affected by the incomplete

magnetization recovery. However, it is evident that the signal intensity at the renal medulla was
further suppressed because of the lower oxygenation and longer 19F T1 in this region.

Figure 6.2

19

F MRI determined functional mapping and quantification in healthy kidneys. (a-b)

Representative quantitative renal blood volume and oxygen tension mapping generated from 19F
MRI of healthy kidneys. (c) Representative 1H T2* mapping of healthy kidneys. (d-f)
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Quantification of functional indexes in different anatomical regions. Data are presented as mean
≤ std. (C-M: cortico-medullary, *: p<0.05).
6.3.2 Quantitative blood volume and oxygenation mapping in healthy kidneys
Heterogeneous distribution of renal blood volume and intrarenal oxygenation was
confirmed in the quantitative parametric mapping of 1H T2*, RBV and pO2 as illustrated in
Figure 6.2 (a-c). Absolute quantification of these functional indexes in different regions of
kidneys is summarized in Figure 6.2 (d-f). Specifically, with 1H BOLD MRI, both the renal
cortex and medulla exhibited significantly longer 1H T2*, suggesting higher tissue oxygenation,
than did the cortico-medullary junction. This inaccurate BOLD readout of high oxygenation in
the hypoxic inner medulla has previously been recognized as a technical limitations of BOLD
MRI in the kidney (43).
19

F MRI of renal blood volume revealed inhomogeneous blood supply to different

anatomical regions of the kidney. To wit, the measured renal blood volumes (in units of volume
fraction per voxel or tissue weight) were: 19 ≤ 2 % in the cortex, 13 ≤ 2 % in the corticomedullary junction and 33 ≤ 5% in the medulla, respectively (p<0.05, for all different regions).
The vascular pattern detected with

19

F MRI is consistent with previous studies that have

employed ex vivo micro CT (44). With the use of the measured ex vivo calibration curve relating
19

F R1 and oxygen tension:

R1( s −1 ) = 0.0032 × pO2 ( mmHg ) + 0.72 ,

[5]

oxygen tension mappings were acquired under conditions of ventilation with pure oxygen. The
cortical pO2 (361≤ 67 mmHg) was significantly higher than that in the cortico-medullary
junction (138 ≤ 66 mmHg) or medulla (30 ≤ 20 mmHg) (p<0.05, for comparison among all three
regions).
128

Figure 6.3 Representative 1H T2*-weighted image,

19

F spin density weighted image and pO2

mapping in contralateral and injured kidneys. The inserted panel in (f) represents the

19

F

oxygenation mapping during ischemia. White arrow points to the cortico-medullary junction and
the white cross identifies the renal medulla.
6.3.3 1H and 19F MRI of kidneys after ischemia-reperfusion AKI
Figure 6.3 shows representative 1H T2*-weighted images,19F spin density weighted
images and

19

F pO2 mapping of injured and contralateral kidneys. At 24 hours after ischemia-

reperfusion, 19F MRI revealed a complete recovery of 19F signal intensity (reflecting restoration
of blood volume), pO2 and 1H T2* in the cortex region of injured kidneys (Figure 6.4a-c). In the
cortico-medullary junction of injured kidneys, 19F signal intensity decreased approximately 25%
(p < 0.05) and 1H T2* increased approximately 70% (p<0.01), which is likely a consequence of
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edema and thrombosis (Figure 6.4a&c). In the renal medulla region,
detected 71% higher

19

19

F and BOLD MRI

F signal intensity (p<0.01) and 40% lower 1H T2* value (p<0.05) in the

injured kidneys as compared with contralateral kidneys, which may be associated with vascular
leakage and hemorrhage-induced intrarenal retention of PFC NPs (Figure 6.4a&c). As for the
intrarenal oxygenation defect, even though we did observe complete desaturation during
ischemia (Figure 6.3f, insert), at 24 hours after transient ischemia-reperfusion, 19F MRI revealed
that intrarenal oxygenation had recovered to normal level (Figure 6.4b).

Figure 6.4 Absolute quantification of 19F signal intensity (a), pO2 (b) and 1H T2* (c) in different
anatomical regions of both contralateral and injured kidneys at 24 hours after injury. Data are
presented as mean ≤ std. (*: p<0.05 and **: p<0.01).
6.3.4 Histology and fluorescence image
Endothelial staining with FITC-lectin demonstrated the reduced perfused micro-blood
vessel density at the cortico-medullary junction (Figure 6.5a). Fluorescence microscopy of PFC
NP confirmed the accumulation of PFC NP within the renal medulla in comparison to the
uninjured contralateral kidneys (Figure 6.5b). By co-registering the FITC-lectin endothelial
staining with the fluorescent PFC NP (Figure 6.5c), we observed that PFC NP accumulated
within extravascular spaces in injured kidneys, suggesting that the high PFC NP concentration at
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the renal medulla could be attributed to the vascular leakage expected under conditions of severe
endothelial injury. H&E staining revealed extensive tissue damage and necrosis at the corticomedullary junction and in the medulla regions of injured kidneys (Figure 6).

Figure 6.5 Fluorescence image of injured and contralateral kidneys. (a) Top row: overview
fluorescence image of FITC-lectin for visualizing perfused blood vessels in contralateral and
injured kidneys. Bottom row: zoomed-in view of FITC-lectin fluorescence image in the corticomedullary junction. (b) Top row: overview fluorescence image of PFC NP in contralateral and
injured kidneys. Bottom row: zoomed-in view of PFC NP fluorescence image in the renal
medulla. (c & d) Merged FITC-lectin and PFC NP fluorescence image of renal medulla
confirmed that PFC NP leaked out from blood vessels and accumulated in the extravascular
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space of injured kidneys as indicated by white arrows. (Red: PFC NP, Blue: DAPI, Green: FITClectin).

Figure 6.6 H&E staining of contralateral and injured kidneys. In both sub-figures, the top left
panel is an overview of the kidney tissue and the other three panels are the high resolution
pictures in different anatomical regions as indicated by dark arrows. H&E staining revealed
extensive tissue damage and necrosis in the cortico-medullary junction and in the medulla (C:
cortex, CM: cortico-medullary junction, M: medulla).
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6.3.5 Treatment effect of PPACK NPs evaluated with 19F MRI
At 3-hour after reperfusion, composite 1H/19F images (Figure 6.7a&b) showed less

19

F

signal (color coded) emanating from trapped NPs in an injured kidney treated with therapeutic
PPACK PFC NPs versus an injured kidney treated with plain PFC NPs (mostly concentrated at
the renal medulla region).

19

F spectroscopic quantification (Figure 6.7c) confirmed a higher

number of trapped blood pool NPs, reflecting intrarenal coagulation, in I/R injured kidneys than
that in contralateral uninjured kidneys of the same mice. Among I/R injured kidneys, however,
substantially fewer NPs were detected in those treated with PPACK NPs reflecting its positive
effect on inhibiting intrarenal coagulation.

Figure 6.7 Ev vivo

19

F image and quantification for retained PFC NP in ischemia-reperfusion

injured kidneys with PPACK NPs and plain NPs pre-treatment. *, p<0.05 compared to
contralateral uninjured kidneys; †, p< 0.05 compared to plain NP treated kidneys.
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6.4 Discussion
Renal endothelial damage is a primary pathology of AKI. It leads to persistent
inflammation and coagulation that hampers effective oxygen delivery, resulting in sustained
injury to tubular cells even after the resumption of renal blood flow in the “extension phase” of
AKI (45). The extent of non-perfusion is more severe in the renal medulla and cortico-medullary
junction than in the cortex (33,46-47). Unfortunately, the interplay between inflammation and
coagulation in AKI remains incompletely understood, due in part to the lack of appropriate
multiparametric approaches for accurate staging of the disease process in vivo that might
contribute to more accurate risk assessment and prognostication (48).
To that end, in the present study we have developed a new

19

F MRI approach for

functional kidney imaging that takes advantage of the quantifiable properties of circulating PFC
NP. As an initial proof of concept, we have demonstrated the feasibility of combining spin
density weighted and T1-weighted

19

F images of circulating PFC NP for quantification of renal

blood volume and oxygenation. We further demonstrated that by integrating parametric
mappings generated from

19

F MRI and conventional BOLD MRI, a more comprehensive

diagnostic matrix for evaluating renal function and physiology is possible. The diagnostic
capability of the proposed multi-function imaging method was evaluated in an experimental
renal ischemia-reperfusion model of AKI. In this animal model,

19

F MRI clearly delineated the

anticipated medullary vascular leakage as a pathophysiological consequence of severe
endothelial damage. Moreover, 19F MRI successfully defined the expected reduced blood volume
at the cortico-medullary junction, indicating vessel occlusion as evidenced by lower density of
perfused blood vessels detected with fluorescence imaging. Finally, the reduced blood volume
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was associated with increased regional 1H T2* in the cortico-medullary junction as revealed by
BOLD MRI.
These clinically translatable renal imaging techniques should expand the armamentarium
for functional renal imaging in patients with existing or new onset kidney disease. The use of
traditional functional imaging schemes, such as iodine contrast based CT and Gd based MRI, are
significantly restricted in patients with renal insufficiency (11). Indeed, the use of such contrast
media accounts for 10% of hospital acquired renal failure in the United States (13,20).
Circulating PFC NP may offer a safer contrast agent for functional kidney imaging for several
reasons. Firstly, PFC NP has been clinically approved as a blood substitute for decades, and to
date no renal toxicity has been reported, owing in part to clearance through liver and lung portals
instead of renal filtration. Therefore, intravenous PFC NPs are not expected to exert additional
toxic strain on kidneys. Secondly, the unique 19F signal emanating from the PFC moieties in the
core of the nanoparticle can be detected readily with
nuclei,

19

19

F MRI. As compared to other imaging

F exhibits a high gyromagnetic ratio, and generates comparable magnetization to 1H

nuclei in an external magnetic field. We anticipate that fully optimized imaging protocols would
enable the entire procedure of 19F functional kidney imaging to be conducted within a clinically
relevant time frame (<30 minutes in the present study). Thirdly, non-invasive estimates of
intrarenal oxygen tension can be derived from

19

F R1, because

19

F R1 is linearly responsive to

local oxygen tension over a wide range of values, and the oxygen exchange between blood and
PFC occurs by free diffusion on a millisecond time scale (49).
Our non-invasive measurement of renal blood volume and oxygenation is consistent with
previously reported ex-vivo (44) and invasive measurements (6,50-52). Accurate delineation of
the distribution of renal blood volume and intrarenal oxygenation is important because of its
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unique pattern and pathophysiological implications. In healthy kidneys, both the renal artery and
vein branch into smaller blood vessels to perfuse the renal cortex, which is critical for
maintaining a physiological glomerular filtration rate (GFR). It is notable that only a small
portion of renal blood flow supports the capillary beds of the collecting ducts at the corticomedullary junction and medulla. Despite this marginal blood supply, the epithelial cells of the
collecting duct still must function at a high metabolic level to support the functioning of various
ion channels for urine concentration, and thus must operate at the hypoxic margin even under
physiological conditions, as evidenced by the steep oxygenation gradient from renal cortex to
medulla. Accordingly, the use of noninvasive

19

F MRI to depict the inhomogeneous blood

volume distribution and oxygenation gradient within the kidney could serve as a translational
tool for future studies of renal pathophysiology in AKI.
We utilized the mouse ischemia-reperfusion AKI model for evaluating the proposed19F
functional kidney MRI techniques because endothelial damage of the renal micro-circulation is a
key component in this model. Extensive interaction between inflammation and coagulation takes
place in AKI (33) and the endothelial damage elicits persistent tubular epithelial dysfunction
even after reperfusion (46), which mimics human pathophysiology. Because of the unique
vascular geometry found in the kidney, coagulation is most severe at the cortico-medullary
junction and the medulla region (53). Persistent ischemia here will disturb normal fluid filtration
and re-absorption, leading to worsening renal dysfunction and/or failure (54). Our

19

F MRI

results together with histological assessment and BOLD MRI confirmed the micro blood vessel
non-perfusion in this region. Additionally, it has been observed that acute ischemic/hypoxic
injury disrupts the normal blood vessel barrier, resulting in intrarenal hemorrhage and vascular
leakage (55). PFC NPs, with a size of 250 nm, under normal circumstances function mostly as an
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intravascular agent that does not permeate the physiological vascular barrier. However, in injured
kidneys, a substantial accumulation of PFC NP was observed within the renal medulla in
extravascular spaces as a consequence of severe endothelial damage. The comprehensive
functional evaluation with

19

F MRI, BOLD, and fluorescence imaging offers an alternative

approach for examining vascular barrier disruption in vivo, as we have shown previously for
advanced atherosclerosis (56). This technique exhibits practical translational advantages over
conventional optical imaging (e.g., Evans blue dye) that is not clinically utile (55). Finally, the
measured improvement of renal oxygenation imaged after 24 hours of reperfusion in this model
indicates potential utility for following kidney damage after AKI and quantifying its responses to
therapeutic interventions.
Although PPACK is a potent thrombin-inhibitor with an excellent safety profile (LD50 >
50 mg/Kg), it has little in vivo effect because of the short elimination half-life (~3 minutes) (57).
Conjugating PPACK to PFC NPs extended the drug elimination half-life to several hours. In
addition, the deposited PPACK NPs on the clot surface manifested prolonged anticoagulation
activity even after the systematic effect was diminished (37). Here we demonstrated PPACK
PFC NPs effectively inhibit coagulation in AKI in small quantities, as evidenced by lesser
accumulation of particles trapped by the clotting process, which suggests a new strategy for
treating and evaluating kidney endothelial damage with thrombin targeted 19F MRI.
With respect to limitations of 19F functional renal imaging, because PFC NP that generate
the

19

F signal for MRI are present in circulating blood, certain flow effects could distort the

quantitative readout of perfusion metrics. Also, at higher field strengths, paramagnetic
deoxygenated hemoglobin generates strong local field inhomogeneities that could significantly
reduce the signal to noise ratio of

19

F MRI in the kidney. To mitigate this effect, quantitative
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mapping of renal blood volume and oxygenation were performed only when mice were breathing
pure oxygen. Further modifications of the imaging pulse sequences might be considered in the
future to enable functional
temporal resolution of

19

F kidney MRI under normoxic conditions. Finally, the limited

19

F MRI currently poses an obstacle for capturing the first pass of the

contrast agent through the renal circulation. Therefore, certain dynamic parameters such as
transient time and renal blood flow rate cannot be determined from these 19F MRI measurements.
Again, optimizations in pulse sequence and RF coil design and performance could ultimately
enhance detection sensitivity and enable applications that require higher temporal resolution.
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7 Conclusion
In this dissertation, we first revisited the general background of molecular and functional
imaging via MRI with a special focus on

19

F MRI of PFC NP based contrast agents. We

performed a thorough examination, both theoretically and experimentally, of the NMR/MRI
properties of PFC NP, including chemical shifts, J-coupling and J-modulation, oxygenation and
paramagnetic relaxation enhancement of

19

F nuclear spins through their interaction with Gd

chelates. Regarding the fundamental MR engineering for in vivo

19

F MRI of PFC NP, we

developed a generalized strategy for designing 1H/19F dual frequency RF coils, which laid the
groundwork for subsequent

19

F MR pulse sequence development and preclinical applications.

Based on an understanding of the NMR physics of 19F MRI of PFC NP, we developed two novel
functional imaging techniques for: (1) noninvasive measurement of the oxygenation of flowing
blood; and (2) multi-parametric functional imaging for evaluating the renal microcirculation and
its pathological changes in standard models of acute renal ischemic injury.

7.1 Summary of major findings
In Chapter 2, we used the coupled-resonator model to develop a single-input dual
frequency strategy for building birdcage and saddle coils that function at both 1H and

19

F

frequencies on a 4.7 T MRI scanner. The excellent matching properties and the homogeneity of
B1 field were confirmed by S11 and S21 test measurements and by in vivo imaging in the
C57BL/6 mouse. To enhance sensitivity, we integrated an actively decoupled surface coil with
the dual frequency volume coils and increased the local SNR by 10 fold. As the structure of the
volume coil was preserved, the sensitivity profile of the new dual frequency RF coils was
essentially identical at 1H and 19F resonant frequencies.
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In Chapter 3, we calculated the relationship between J-modulation of a representative
PFC molecule (PFOB) and the imaging RF pulse bandwidth. Density matrix and experimental
analyses suggested that narrow band RF pulses could suppress the J-modulation in 19F spin echo
imaging. By employing Bloch equation modeling, we also simulated the oxygenation effect on
19

F quantification. We showed that absolute quantification of the 19F MR signals from PFC NP

is insensitive to the oxygen concentration as long as TR> 3* T1, and moreover that shorter TE
always facilitate the achievement of greater

19

F sensitivities even in the presence of the J-

coupling effect. In the end, we took advantage of the multiple and widely separated chemical
shifts of PFC NP to implement a “multi-chromatic” 19F MRI technique that is capable of imaging
at least five different PFC components in the same phantom using ultra narrow band RF pulses.
The feasibility of “multi-chromatic”

19

F was demonstrated in vitro in cellular imaging studies

and in vivo with 19F MRI of a mouse leg.
In Chapter 4, we demonstrated that the 19F signal strength emanating from PFC NP could
be enhanced by incorporating a large number of paramagnetic moieties (Gd) into a monolayer
lipid membrane surrounding a

19

F core. Our results showed that

19

F T1 shortening can be

attributed to the Brownian motion of core PFC molecules inside the NP. An explicit expression
for the relaxation enhancement was derived to describe the physical mechanisms that lead to
enhanced longitudinal relaxation of 19F nuclear spins. The theoretical description was confirmed
experimentally by field-dependent T1 measurements. The interaction between

19

F nuclear spins

and Gd electron spins was observed to be highly dependent on the separation distance between
them, which results in a “relaxation switch” phenomenon, which could be used to detect cellular
processing of the contrast agent by macrophage endosomal activation. Specifically, after
paramagnetic PFC NP was internalized by macrophages through endocytosis, endosomal
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processing stripped the lipid surfactant layer containing the Gd away from the PFC core,
resulting in the separation of
outer sphere influence on

19

19

F and Gd atoms beyond the point where the Gd could exert an

F relaxation, leading rapidly to complete elimination of the

exogenous relaxation enhancement of 19F T1.
In Chapter 5, we developed a novel Blood flow-Enhanced-Saturation-Recovery (BESR)
sequence, which allowed rapid in vivo T1 measurement of blood for both 1H and

19

F nuclei.

BESR sequence was achieved by combining homogeneous spin preparation and time-of-flight
image acquisition, which served to preserve both efficient imaging and SNR for 19F imaging of
circulating PFC NP. The consistency and accuracy of the BESR sequence for measuring T1 of
blood was validated experimentally. After confirming the linear response of 19F R1 to increasing
oxygen tension in both salt solutions and blood samples in vitro, we demonstrated the utility of
the BESR sequence for quantification of oxygen tension within the mouse left and right
ventricles under both normoxic and hyperoxic conditions.
In Chapter 6, we developed a unique sensor-reporter approach for functional kidney
imaging that employs circulating PFC NP and

19

F MRI. Our noninvasive in vivo

19

F MRI

technique generated quantitative readouts of renal blood volume and intrarenal oxygenation to
describe the renal circulation in healthy mouse kidneys. In a mouse model of acute kidney injury
(AKI, warm ischemia-reperfusion), we sensitively delineated renal vascular damage and
recovery with the use of the proposed 19F functional MRI strategy, in conjunction with 1H BloodOxygenation-Level-Dependant (BOLD) MRI. In the cortico-medullary junction region, we
reported a 25% lower 19F signal (p<0.05) and 70% longer 1H T2* (p<0.01) in injured kidneys
as compared with the contralateral kidneys by 24 hours after initial ischemia-reperfusion injury.
We also detected 71% greater

19

F signal (p<0.01) and 40% lower 1H T2* (p<0.05) in the renal
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medulla region of injured kidneys compared to contralateral kidneys. Moreover, with the use of
ex vivo

19

F MRI, we determined that PPACK PFC NPs effectively inhibit microvascular

coagulation in AKI, as evidenced by reduced accumulation of particles trapped by the ongoing
clotting process, which suggests a new strategy for treating and evaluating kidney endothelial
damage with thrombin targeted 19F MRI.

7.2 Future works
7.2.1 Applications of “relaxation switch”
The “Relaxation switch” phenomenon first reported in this work could serve as a new
approach to evaluate the uptake and processing of PFC NP by myriad tissues. By measuring 19F
T1 of paramagnetic PFC NP, one might dynamically track the intracellular processing and
disposition of these particles. In many applications, it is important but difficult to identify
whether PFC NPs accumulate in intracellular environments or only are trapped locally in the
extracellular matrix: if processed rapidly intracellularly, the “relaxation switch” approach could
offer more direct insights into such cell processing mechanisms.
7.2.2 Tracking multiple biomarkers in vivo
The multi-chromatic 19F technique could be readily applied to several clinically relevant
disease models to elucidate the presence of multitudinous biomarkers. For example, in the
coagulation process, thrombin cleaves fibrinogen to fibrin, which deposit in thrombi along with
platelets that are activated by thrombin. Many thrombin-inhibiting drugs, including the PPACK
PFC NP that was investigated in this dissertation, diminish the coagulation process by actively
binding to and irreversibly inactivating thrombin. Therefore, to better evaluate the treatment
effect and investigate the clotting pathology, it might be helpful to quantify both the presence of
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the anti-thrombin drugs and the molecular target itself, fibrin, in the clot, which would facilitate
pharmacokinetic and pharmacodynamic assessment over time. Such applications could be
realized in a non-invasive manner by combing the multi-chromatic

19

F imaging technique with

fibrin-targeted PFC NPs and anti-thrombin PFC NPs which are already available.
7.2.3 Relation between cellular pO2, tissue pO2 and vascular pO2
Because of the relatively large size of PFC NPs, which remain intravascular, the
oxygenation measurements reported in this dissertation actually represent the pO2 in micro and
macro vasculature. However, because of the limited diffusivity of O2 in biological tissues, the
pO2 in soft tissues remote from the flowing blood supply could be dramatically different from
vascular oxygen levels. Likewise, local interstitial pO2 also would exceed intracellular pO2. For
example, in many tumor models, most cancer cells might function under highly hypoxic
environment especially in under-perfused regions. However, many observations have suggested
that intravascular pO2 in tumor tissue might be even higher than in normal microvasculature;
possibly due to the special arrangement of blood vessels in solid tumors that hinders effective
diffusion of O2 from blood to hypoxic tumor tissues. It is possible then by using different PFC
NPs to label tumor cells themselves, tumor vasculature, and extracellular tissue space, we could
fully delineate the pO2 differences in various compartments by imaging each PFC NP component
individually.
7.2.4 Dynamic monitor of functional change in AKI kidneys
We have demonstrated the feasibility of using 19F MRI to evaluate endothelial damage in
AKI kidneys. As a next step, it would be germane to perform follow-up imaging studies at
different time points after the initial surgery to fully map out the recovery process. Also,
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investigation of more severe extents of injury by extending the ischemia time could be useful for
developing methods more predictive of ultimate recovery or failure.
7.2.5 In vivo evaluation of treatment effect of PPACK NP for AKI
We also demonstrated in vivo
19

kidney and ex vivo

19

F functional imaging of ischemia-reperfusion injured

F imaging for evaluating the treatment effect of PPACK NP on injured

kidneys. Going forward, it would be critical to perform in vivo

19

F MRI to evaluate treatment

effects in this disease model. In particular, delivering one PFC NP as drug delivery vehicle and a
different type of PFC NP as a contrast agent could utilize multi-chromatic 19F MRI techniques to
generate both a parametric mapping of renal microcirculation and quantitative readout of the
concentration of the anti-thrombosis drug.
7.2.6 Combining

19

F oxygenation and 1H phase contrast imaging for oxygen consumption

measurements
The new

19

F BESR sequence might find other uses for measuring blood oxygenation in

large blood vessels. For example, in combination with

19

F oxygenation mapping, 1H phase

contrast angiography could provide a quantitative estimate of blood velocity. Together, the pO2
and blood flow information would allow the calculation of tissue oxygen consumption, which is
an important metabolic index of organ viability and functionality. This technique could be tested
in brain, lung, kidneys, heart and other organs for proof of concept, under normoxic and
ischemic conditions.
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7.2.7 Combining VCAM targeted scheme with PPACK NP for targeted imaging and
treatment
It is known that the interplay between inflammation and coagulation plays a pivotal role
in the persistence of renal endothelial damage in AKI. By functionalizing anti-thrombin PPACK
NP with an anti-VCAM-1 peptide, we might enhance the focal accumulation of therapeutic
PPACK NPs in inflammatory vessels that manifest upregulated VCAM-1 as a part of the
inflammatory process. The VCAM-1 targeted PPACK NP might be especially beneficial for
therapy of evolving AKI, because a large component of the inflammatory responses ensues after
reperfusion. Again, ex vivo

19

F quantification and in vivo functional

19

F imaging techniques

might prove useful for following the treatment effect of this new nanodrug approach.
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